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1 Abstract 
Background  
Type 1 Diabetes (T1D) is a chronic autoimmune disease in which a selective destruction of 
the insulin-producing β-cells in the pancreas results in insulin deficiency and hyperglycaemia, 
thus a dependance on exogenous insulin for survival. It is one of the most common chronic 
diseases in childhood and adolescence, and the incidence is increasing worldwide. Children 
and adolescents with T1D are at increased risk of developing psychiatric disorders and many 
report reduced quality of life. This emphasizes the importance of diabetes care by a highly 
qualified multidiciplinary team which includes mental health workers. 
Aim  
The aim of this study was to illustrate current research on psychosocial care for children and 
adolescents with T1D around the world, and to compare the diabetes care in Norway and 
Australia, mainly focusing on the organisation of diabetes teams and their attention towards 
the patient’s mental health.  
Methods  
The thesis is divided in two parts. Part one is a literature review on T1D based on a non-
systematic PubMed search, mainly focusing on mental health among children and adolescents 
with T1D. In part 2, the care for young patients with T1D at Oslo University Hospital (OUH) 
in Oslo, Norway, Royal Children´s Hospital (RCH) in Melbourne, Australia, Alice Springs 
Hospital (ASH) in Alice Springs, Australia and John Hunter Hospital (JHH) in Newcastle, 
Australia is presented. The discussed results are based on information gathered using a 
standardized electronic questionnaire on T1D, based on international guidelines for diabetes 
care, and personal experiences.  
Results 
At RCH and ASH, the most common treatment regime was twice-daily insulin injection 
unlike OUH and JHH where multi-injection therapy and insulin pump was most commonly 
used. Nevertheless, the average HbA1c was quite similar. All the presented hospitals used 
guidelines in their clinics. However, at ASH the recommended screening programs were not 
followed and no social worker nor psychologist was included in the diabetes care team. Even 
though the other three hospitals (OUH, RCH, JHH) had multidiciplinary diabetes care teams 
as advocated in The International Society for Paediatric and Adolescent Diabetes (ISPAD) 
guidelines, only one of these teams (OUH) include a psychologist. Comprehensive education 
and care was offered at all the hospitals, but the lack of organized reeducation and limited 
knowledge about their patients mental health was an important finding. Only OUH had 
organized reeducation for adolescents.  
Discussion 
At all the presented hospitals children and adolescents with T1D had access to recommended 
insulin preparations and treatment regimens, and the treatment and follow up was well 
organised. However, keeping in mind the high risk of developing mental health problems 
among these patients, an increased focus on psychosocial health should be implemented in the 
diabetes management. Furthermore, regular re-education might be helpful in understanding 
the disease and thus coping better. Coping is essential for good glycaemic control and for the 
patient’s quality of life.  
Conclusion  
Achieving both metabolic and psychological stability in children and adolescents with T1D 
requires a multidisciplinary diabetes team that is equipped to provide physical, social and 
psychological support. A psychologist should be a compulsory part of the diabetes team and 
psychological interventions, such as screening programs for psychological issues, should be a 
part of the of diabetes care for young people. 
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3 Abbreviations 
ALO Aboriginal Liaison Officer  
APEG Australian Paediatric Endocrine Guidelines 
ASH Alice Springs Hospital 
BMI Body Mass Index 
BG Blood Glucose 
BGL Blood glucose Level 
BGM Blood Glucose Monitoring 
CBGM Continuous Blood Glucose Monitoring  
CSII Continuous Subcutaneous Insulin Infusion 
DAWN Diabetes Attitudes, Wishes and Needs 
DKA Diabetic Ketoacidosis 
DSME Diabetes self-management education 
HbA1c Haemoglobin 1c 
IDF International Diabetes Federation 
IDDM Insulin-Dependant Diabetes Mellitus 
ISPAD  The International Society for Paediatric and Adolescent Diabetes 
JHH John Hunter Hospital 
MDI Multiple Daily Injections 
NCDR Norwegian Childhood Diabetes Registry 
NDR National Diabetes Register (Australian) 
NEDEC New England Diabetes and Endocrinology Center  
NPH Neutral Protamine Hagedorn Insulin 
NSW New South Wales 
NT Northern Territory 
OECD Organisation for Economic Co-operation and Development  
OUH Oslo University Hospital 
PYR Person Years 
QoL Quality of Life 
RCH Royal Children’s Hospital 
SMBG Self-Monitoring of Blood Glucose level 
T1D Type 1 Diabetes 
T2D Type 2 Diabetes 
WE-CARE Well-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire  
WHO World Health Organization 
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4 INTRODUCTION 
4.1 Background 
Diabetes mellitus is a group of metabolic diseases, characterized by chronic high levels of 
blood glucose resulting from defects in insulin production, insulin action or both. The 
majority of diabetes cases are either Type 1 diabetes (T1D) or Type 2 diabetes (T2D) [1]. 
T1D results from a cellular autoimmune destruction of the insulin-producing β-cells in the 
pancreas leading to insulin deficiency [2], while  T2D  is caused by a combination of 
resistance to insulin action and inadequate compensatory insulin secretory response [1].  
 
There has been a worldwide increase in T1D during the last years [3]. According to WHO 
Multinational Project for Childhood Diabetes, T1D, also known as Insulin-dependant diabetes 
mellitus (IDDM), ”is one of the most important chronic diseases of children worldwide” [4]. 
This emphasizes the importance of strategies to improve diagnosis, treatment, and prevention 
of complications among children and adolescents with the disease.  
4.2 Aims 
The aims of this student thesis were to compare the diabetes care for children and adolescents 
with T1D in Norway and Australia, two countries in very different parts of the world, mainly 
focusing on the organisation of diabetes teams and their focus on the patient’s mental health. 
According to DAWN (Diabetes Attitudes, Wishes and Needs) Youth the support available 
today for children and their families is far from optimal, even in the most developed countries 
[5].  
 
Furthermore, the thesis is a part of the larger study “ Diabetes in children; a global 
comparative study”.  Several medical students are travelling to different countries around the 
world to study and compare the management of diabetes in children and adolescents. An 
important question raised in these comparisons is “Are the clinical practice consensus 
guidelines from the International Society of Paediatric and Adolescent Diabetes (ISPAD) 
adhered to?” The study is based on literature reviews and a standardized questionnaire.  
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4.3 Subject and methods 
This thesis is divided into two parts. Part one is a literature review on T1D, mainly focusing 
on mental health among children and adolescents with diabetes. A non-systematic PubMed 
search was performed to gather information on T1D. 
 
Part two is a clinical part consisting of results from a standardized semi-qualitative 
questionnaire (appendix 1), and personal experiences from hospitals in three different states 
of Australia and the capitol of Norway. The semi-qualitative questionnaire was designed to 
gather information about children with diabetes ≤ 15 years of age. The interview was split in 
two rounds.  The first part of the questionnaire was designed to map T1D in children at a 
national or regional level. This was filled out based on information from the Internet and 
other available sources, and then talked through with a local informant. The second part of the 
questionnaire was designed to map T1D in children at the local hospital/treatment facility. 
Prior the interview the questionnaire was sent to the informant so that he or she could prepare 
himself/herself. The questionnaire contained multiple qualitative questions and was therefore 
tape-recorded.  
 
In addition to Internet searching and personal interviews some answers to the questionnaires 
were collected via email from informants at the hospitals/treatment facilities.  
 
The questionnaire at Oslo University hospital (OUH), in Norway, was completed a month 
prior the departure to Australia. Diabetes nurse, Siv Janne Kommernes, at the Children’s 
department was interviewed. The outpatient clinic was also visited.  
 
The interview at the Royal Children´s Hospital (RCH) in Melbourne in Victoria, Australia, 
took place in the third of a four-week clinical rotation. The clinical rotation consisted of daily 
work at the Department of Endocrinology and Diabetes, which included visiting in-patients 
with newly diagnosed T1D and admissions of other patients with known T1D regarding 
stabilization and re-education, visits to the Emergency Department where children with DKA 
were treated, diabetes-meetings with the consultants, fellow doctors, registrants and diabetes 
allied health team, out-patient diabetes clinics and diabetes education.   
 
- 9 - 
At Alice Springs Hospital (ASH) in Northern Territory, Australia, a diabetes educator and one 
of the paediatric consultants were interviewed. Although very few children with diabetes are 
treated here sufficient information was gathered to include the hospital in the study.  
 
At John Hunter Hospital (JHH) in New South Wales, Australia, an endocrine paediatrician 
was interviewed and few outpatient clinics were visited.  
 
The schemes did not contain personal sensitive information. 
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5 PART ONE – Literature review on type 1 diabetes in 
children and adolescents 
5.1 Epidemiology 
5.1.1 World 
T1D is one of the most common endocrine and metabolic diseases among children and 
adolescents and the incidence, especially in children younger than 15 years, is increasing all 
over the world. The annual incidence increase in this age group is 3 % [3]. In 2010 the 
prevalence was 479 600 thousand between 0 and 14 years and the number of newly diagnosed 
children was 75 800 [3]. 
 
The incidence of T1D in children varies based upon geography [6], age [7-9] and family 
history [10]. In most populations around the world girls and boys are equally affected [11].  
 
The increase in yearly incidence appears to be primarily in the younger age group. However, 
both in Norway and Australia the increase is largest in the age-group 10-14 years [12-14]. In a 
multicentre study from Europe where 17 European countries were included, an overall annual 
incidence rate increase of 3.9 % was revealed over a period of 15 years. The incidence rise 
was clearly highest in the youngest age group. Between 1989 and 2003 the incidence of T1D 
increased with 5,5% in children 0-4 years of age, 4.3% in the age group 5-9 years and 2.9 % 
in the age-group 10-14 years [15]. 
 
There is a substantial variation in incidence rates of T1D among children internationally. In 
worldwide research conducted by the International Diabetes Federation (IDF), Norway and 
Australia are both found to be amongst the top 10 countries in incidence rates for T1D in 
children 0-14 years old [16]. According to IDF, Finland had the highest incidence rate of 57.4 
per 100 000 person-years (PYR) in 2010, followed by Sweden, Norway, the United Kingdom 
and Australia. Denmark, Canada and the USA are also high up on the list [16].  Fiji and 
Venezuela are among the countries with the lowest incidence rates (0.1 per 100 000 PYR) 
[16]. 
 
 
- 11 - 
Table 1: The global incidence rate of Type 1 Diabetes aged 0-14 years in 2006.  
 
Source: International Diabetes Federation. Available from: http://www.idf.org 
5.1.2 Norway  
Norway is amongst the countries with the highest incidence of T1D in the world and the rate 
is increasing [17]. In 1973 the incidence was 19 per 100 000 PYR among children between 0 
and 14 years [18]. Between 1999 and 2003 the annual incidence was 28 per 100 000 PYR and 
in 2008 the incidence was increased to 33 per 100 000 PYR (Table 2a) and to 36 per 100 000 
in 2009 [12].  
 
In year 2009 361 new children, under the age of 18 years, were registered in the Norwegian 
National Diabetes Registry with a diagnosis of diabetes, 45% (163) girls. T1D was the most 
common diagnosis (98%). Among the total amount of registered patients, 335 (93%) were 
younger than 15 years at the time of diagnosis, and among these, 331 children had T1D (99%) 
[12]. Among the children with T1D that attended the yearly check-ups in 2009; 4% were 
younger than five years, 18% were between few and nine years and 45% between 10 and 14 
years. The numbers are based on data from the National Childhood Diabetes Registry 
(NDCR) [12], a prospective population based registry for childhood diabetes in Norway. 
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Table 2a: Incidence and prevalence of type 1 diabetes in children < 15 years in Norway 
(year 2008)  
 Norway 
Incidence of T1D < 15 years 33 per 100 000 PYR 
Prevalence of T1D < 15 years Approx. 2700 
Source: Annual report 2008, the Norwegian Childhood Diabetes Registry  
5.1.3 Australia  
Australia is also on the top-ten-list of countries with the highest 
incidence rates of T1D in children [14]. In the time period 
between 2000 and 2008 the average annual incidence of T1D 
among children aged 0-14 years in Australia was 22.8 per 100 
000 PYR, with an increasing rate of 1.7% per year.  The rate 
increased most in the period 2000-2004, with an average rate of 
6%. Overall in the whole time period the annual rate was highest in the age group 10-14 years 
(in 2008), where the rate peaked at 30.9 per 100 000 PYR, with an average increase in rate of 
2.3 %. Among children between 0 and four years and between five and nine years the 
incidence rate increased 0.7% and 2.2% in average, respectively. When comparing boys and 
girls, the incidence increase was significantly higher among boys then girls in the age groups 
0-four years and 10-14 years. The overall incidence rate in 2008 was 23.9 (Table 2b) [14]. 
 
Table 2b: Incidence and prevalence of type 1 diabetes in children < 15 years in year 
2008 in Australia. 
 Australia 
Incidence of T1D < 15 years 24 per 100 000 PYR 
Prevalence of T1D < 15 years Approx. 5000-6000 
Source: Australian Institute of Health and Welfare 2010. Incidence of Type 1 diabetes in Australian 
children 2000–2008. Diabetes series no. 13. Cat. no. CVD 51. Canberra: AIHW, and the Diabetes 
manual at Royal Children´s Hospital.  
 
Australia is a large country and the incidence rate of T1D varies greatly between the states 
with the lowest incidence seen in Northern Territory (NT) and the highest in Tasmania (Table 
2c). The numbers are based on data from the Australian National Diabetes Register (NDR) 
[14], a prospective population based register for people with diabetes living in Australia. 
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Table 2c: Average incidence of Type 1 diabetes in children 0-14 years between 2000-
2008 in the states of Australia 
State	  in	  Australia	   Incidence	  (per	  100	  000	  PYR)	  
New	  South	  Wales	   21.0 
Victoria	   24.0 
Northern	  Territory	   10.2 
Queensland	   23.2 
Tasmania	   28.3 
Western	  Australia	   22.9 
Australian	  Capitol	  Territory	   25.0 
South	  Australia	   25.9 
Source:  Australian Institute of Health and Welfare 2010. Incidence of Type 1 diabetes in Australian 
children 2000–2008. Diabetes series no. 13. Cat. no. CVD 51. Canberra: AIHW. 
5.2 Aetiology and pathogenesis 
T1D is characterized by a selective destruction of the insulin-secreting β-cells in the pancreas, 
leading to insulin deficiency [19]. It is a chronic autoimmune disease, which usually exists in 
a preclinical phase for a while. The classic manifestations such as hyperglycaemia, polyuria, 
polydipsia, weight loss, dehydration, electrolyte disturbances and ketoacidosis occur when 
most of the β-cells have been destroyed [2].   
 
Serological markers of an autoimmune pathological process are present in 85-90% of 
individuals when fasting hyperglycaemia is detected [20]. In up to a third of the patients with 
T1D the autoimmune attack is not limited to the β-cells, and they develop additional 
autoimmune disorders, such as celiac disease, autoimmune thyroid disease (Hashimoto´s or 
Grave´s disease), Addisons´s disease, vitiligo, pernicious anemia and [21]. 
 
Genetic and environmental factors act together to precipitate the disease [22]. The genetic 
susceptibility is most importantly linked to the HLA region on chromosome 6p21 [23]. 
However, other non-HLA loci have been found to be associated with T1D. In the meta-
analysis “Genome-wide association study” from 2009, they found that more than 40 distinct 
genomic locations provided evidence for association with T1D [24]. Nevertheless, only a 
relatively small proportion (<10%) of genetically susceptible individuals progress to a clinical 
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disease [25], implicating that additional exogenous factors are needed to trigger and drive β-
cell destruction in the genetically predisposed subjects. Findings from two case-control 
studies have suggested that there might be an increased risk of developing T1D in genetic 
susceptible subjects that are introduced to cows milk and solid foods in early infancy [26, 27]. 
Enterovirus infections, especially Coxsackievirus B4 infections, are also among the suggested 
environmental risk factors potentially contributing to the development of T1D [28].  
5.3 Diagnostic criteria    
The diagnostic criteria for diabetes are based on blood glucose measurements and the 
presence or absence of symptoms. ISPAD have published the following criteria for 
diagnosing diabetes (Table 3) [29]. 
 
Table 3: The criteria for the diagnosis of diabetes mellitus from The International 
Society for Paediatric and Adolescent Diabetes (ISPAD). 
Criteria for the diagnosis of diabetes mellitus 
1. Symptoms of diabetes plus casual plasma glucose concentration >/= 11.1 
mmol/l (200 mg/dl). Casual is defined as any time of day without regard 
to time since last meal OR 
2. Fasting plasma glucose >/= 7.0 mmol/l (126mg/dl). Fasting is defined as 
no caloric intake for at least 8 hrs       OR 
3. 2-hour postload glucose >/= 11.1 mmol/l (200 mg/dl) during an OGTT. 
The test should be performed as described by WHO, using a glucose load 
containing the equivalent of 75 g anhydrous glucose dissolved in water or 
1.75 g/kg body weight to a maximum of 75 g 
Source: ISPAD Clinical Practice Consensus Guidelines 2009: Definition, epidemiology and 
classification of dabetes in children and adolescents 
5.4 Treatment 
Children and adolescents with T1D are dependent on insulin treatment for survival [30]. The 
aim is to get an insulin replacement as close to normal physiology as possible, and to obtain 
optimal glycemic control. There are many insulin formulations available and many different 
insulin regimens.  
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5.4.1 Medication 
Many formulations of insulin are available around the world (Table 4). A lot of countries use 
mainly insulin analogues in the treatment of T1D [30]. According to ISPAD, these analogues 
and human insulins are better than porcine or bovine insulin, because of low immunogenicity 
[30]. Devices such as insulin syringes, pen injector devices and continuous subcutaneous 
insulin infusion (CSII) or insulin pump are used to administer the insulin.  
 
Table 4: Types of insulin preparations and suggested action profiles according to 
manufactors  
INSULIN TYPE Onset of 
action (h) 
Peak of 
action (h) 
Duration of 
action (h) 
Rapid acting analogs (Novorapid, 
Humalog) 
0.15-0.35 1-3 3-5 
Regular/soluble /short acting 
(Actrapid) 
0.5-1 2-4 5-8 
Intermediate acting Semilente 
(pork) 
1-2 4-10 8-16 
    *NPH (Protaphene) 2-4 4-12 12-24 
    **IZP Lente type  3-4 6-15 18-24 
Basal long-acting analogs 
  - Glargine (Lantus) 2-4 None 24 
  - Detemir (Levemir) 1-2 6-12 20-24 
Long-acting 
  - Ultralente Type 4-8 12-24 20-30 
* NPH=  Neutral Protamine Hagedorn Insulin. **IZP = insulin zinc suspension 
Source: ISPAD Clinical Practice Consensus Guidelines 2009. Insulin treatment. 
5.4.2 Insulin doses 
The daily insulin doses depend on age, weight, stage of puberty, duration and phase of 
diabetes, state of injection sites, nutritional intake and distribution, exercise patterns, daily 
routine, results of blood glucose monitoring and intercurrent illness [30]. When taking all 
these factors into account it becomes clear that regular review and reassessment is required. In 
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the day-to-day life one should concentrate the three main factors; blood glucose, planned food 
intake and planned physical activity, when calculating the insulin doses. 
5.4.3 Treatment regimens 
There are several different insulin treatment regimens. The choice of regime depends on 
factors like the childs age, dietary patterns, exercise, duration of diabetes, school/work 
situation, patient/family/doctors preferences and costs.  Most regimens include a proportion of 
short or rapid acting insulin and intermediate-acting insulin, long-acting or basal analog [31]. 
The following regimens are frequently used: 
 
Twice-daily injection 
The patient injects a mixture of short or rapid acting insulins and intermediate acting insulins 
twice daily. This is done before breakfast and the main evening meal.   
 
Three-times daily  
The patient injects a mixture of short or rapid and intermediate acting insulins before 
breakfast, rapid or regular insulin alone before evening meal and intermediate acting insulin 
before bed, or variations of this.  
 
Multiinjection therapy 
The patient injects insulin four or more times daily. 40-60% of the daily requirement should 
be basal insulin and the rest pre-prandial rapid-acting or regular insulin. The rapid-acting 
analogs are injected immediately before each meal (breakfast, lunch and main evening meal), 
regular insulin must be injected 20-30 minutes before meal and the intermediate-acting 
insulin or basal/long-acting analog is injected twice daily (morning and evening) or only at 
bedtime.  
 
Insulin pump 
The patient has an external pump that injects short-acting insulin in a combination of 
continuous injection (basal) and bolus-injections. This regime has the best possibility of 
imitating the physiological insulin profile [30].  
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5.4.4 Monitoring of glycaemic control 
To obtain a blood glucose level (BGL) close to normal range (3.6-5.8mmol/l) monitoring of 
glycaemic control is essential, in addition to intensive insulin treatment. Monitoring of 
glycemic control includes daily monitoring of BGL at home as well as periodic monitoring of 
overall glycaemia. None of the above mentioned insulin regiments can be optimized without 
such monitoring [32]. 
 
Self-monitoring of blood glucose level (SMBG) 
In the late 1970´s / early 1980´s, T1D patients started using instruments for self-monitoring of 
blood glucose levels (SMBG) [33, 34]. Since that introduction, SMBG has become a keystone 
in the daily management of blood glucose (BG) among patients with T1D. SMBG provides 
immediate documentation of hyperglycemia and hypoglycemia which allows implementation 
of strategies to optimally treat, as well as avoid, BGL out of range.  According to the ISPAD 
guidelines SMBG should be measured four to six times daily [32]. 
  
Urine glucose 
Unfortunately SMBG is an expensive tool and is not available for all patients with diabetes 
around the world. In countries where SMBG is not available, urine glucose is measured 
instead. Urinary glucose reflects glycemic levels over the preceding several hours [32].  
 
Continuous glucose monitoring 
Continuous blood glucose monitoring (CBGM) systems use a small sensor inserted under the 
skin to measure the glucose levels in the interstitial fluid. The sensors are replaced every 3-10 
days and requires calibration two-three times daily. The user must check blood samples with a 
glucose meter in order to calibrate the device [32]. The CGMS provides detailed information 
on glucose fluctuations.  Studies have shown that CBGM identify significantly more episodes 
of hypo- and hyperglycemias, and that  usage of the system is associated with shorter duration 
of the hypoglycaemias [35, 36]. The system does not replace SMBG because approved 
devices are not as accurate and reliable as standard BG meters. 
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Urine and blood ketone testing 
According to ISPAD guidelines, urine or blood ketone measurement should be monitored 
during episodes of uncontrolled hyperglycaemias, insulin deficiency, intercurrent illness and 
impending hyperglycaemia [32].  
 
Glycated haemoglobin, HbA1c 
HbA1c reflects the levels of glycaemia over the preceeding eight-twelve weeks, weighted 
towards the most recent four weeks [32]. Because the most recent glycation is reversible, the 
most recent week is not included.  It has been shown to be the most useful measure to 
evaluate metabolic control. Furthermore it is an important  measure in terms of its relationship 
with late micro- and macrovascular complications [37]. The target for HbA1c in all age 
groups is recommended by ISPAD to be < 7,5% [32]. 
5.4.5 Nutrition and carbohydrate counting 
Nutritional management is an essential and complex part of diabetes care and education in 
children and adolescents. The aims should, according to the ISPAD guidelines, be to provide 
sufficient and appropriate energy intake and nutrients for optimal growth, development and 
good health, and to prevent acute and long-term complications. Furthermore, the aims are also 
to encourage lifelong eating habits, to achieve and maintain the best possible glycemic control 
and ideal body weight and to maintain and preserve quality of life [38]. Growth charts, BMI-
measures and Tanner staging are important tools in monitoring the growth and development.  
 
The primary nutrient that affects postprandial glycemic response is carbohydrates [39].  
Carbohydrate counting is an useful tool in meal planning for patients with diabetes, because it 
allows the patients to have more flexibility in their food choices. Furthermore, studies have 
shown that the use of carbohydrate counting can reduce HbA1c [40].  
5.4.6 Physical activity 
Physical activity is another crucial component for children and adolescents with T1D 
considering both their physical and mental health. Exercise can improve lipoprotein profile, 
increase insulin sensitivity, lower blood pressure and improve cardiovascular fitess and 
quality of life in persons with T1D [41].  To achieve these positive effects, insulin and food 
intake must be carefully planned. During aerobic metabolism the uptake of glucose in the 
skeletal muscle increases in order to make energy for muscle contraction and hepatic 
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gluconeogenesis is suppressed. This leads to a decrease in blood glucose and thus an 
increased risk of hypoglycaemia [42].  Therefore adequate carbohydrate replacement, before, 
during and after excercise is very important to avoid severe hypoglycaemic events. 
Furthermore, a reduction in preprandial short-acting insulin doses is also essential when 
planning physical activity [42].  It can be very beneficial for the children to get accustomed to 
daily, regular excercise, because it will be easier to manage when it is a part of the daily 
routine [43]. Nevertheless, adjustments may still be necessary for sporadic extra physical 
activity. It is good practice to keep careful notes of the timing and intensity of the activity the 
child or adolescent performs, the carbohydrates taken and the blood glucose level before, 
during and after physical activity. This kind of recording is independant of the level of 
involvement in excercise the child or adolescent has adopted [43]. Careful advice considering 
management of diabetes and exercise to caregivers, coaches and teachers, including provision 
of written information, is important.  
5.4.7 Record keeping/diabetes diary 
Recording BGL´s and carbohydrate intake is not only important when performing physical 
activity. It is common practice, and recommended in the ISPAD guidelines, to record patterns 
of glycaemic control and adjustment to treatment every day in a diabetes diary, logbook or 
electronic memory device [32]. Several important factors should be included in the record 
book everyday.  
 
According to ISPAD clinical consensus guidelines the record book should contain [32]: 
• Blood glucose  levels 
• Insulin dosage 
• Notes of special events affecting glycaemic control such as illness, parties, exercise, 
menses ect 
• Hypoglycaemic episodes, including description of severity and potential alterations in 
the usual routine (this is important to help explain the cause of the event) 
• Episodes of ketonuria/ketonemia 
5.5 Ambulatory care/diabetes teams 
Diabetes is primarily managed in outpatient/ambulatory setting. It is essential with a well-
organized and regular ambulatory care for all children with diabetes for optimal blood glucose 
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control and to reduce the risks of acute and long-term complications, but also to optimize the 
children’s quality of life. It is now accepted worldwide that an effective multidisciplinary 
team is crucial for providing good diabetes care to children and adolescents with T1D. One of 
the earliest reports of a multidisciplinary team approach was published by Laron et al in 1979 
[44] . Several positive outcomes were revealed in their study where 262 children with juvenile 
diabetes and their parents were followed up on an ambulatory basis by a multidisciplinary 
team composed of a paediatric endocrinologist, nurse, dietician, psychologist and social 
worker. They found that the degree of glycaemic control increased, there were fewer 
complications and almost no need for hospitalization, the attitudes of the children, their 
families and teachers, were found to be considerably improved, so was the children’s 
motivation to maintain the treatment regime and their self-concept. Furthermore, the conflicts 
in the families were reduced and the children’s achievements at school and social adjustments 
were improved. Thus, they concluded that a multidisciplinary team approach in the treatment 
of T1D seem to be favourable. Although few similar studies have been conducted, 
international guidelines have implemented the use of multidisciplinary diabetes teams in the 
diabetes care for children and adolescents. 
 
According to ISPAD clinical consensus guidelines from 2009 [45], the multidisciplinary 
diabetes care team for children and adolescents, should consist of: 
• Paediatrician specializing in diabetes or endocrinology or a physician with a special 
interest in childhood and adolescent diabetes 
• Diabetes nurse specialist or diabetes nurse educator  
• Dietician or a nutritionist 
• Paediatric social worker with training in childhood diabetes and chronic illness and/or 
psychologist trained in paediatrics and with knowledge of childhood diabetes and 
chronic illness  
 
It is emphasized in the guidelines that the team should recognize the family and child as an 
integral part of the diabetes care team from the day of diagnosis.  
 
In areas of low population density and where childhood diabetes rarely occurs, a 
multidisciplinary team is less likely available. In areas like these the care is likely to be 
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provided by a local physician/practitioner, but there should be access and advice easily 
available from diabetes care teams at regional centres [45].  
 
The diabetes care team should provide expert advice and education for the children with 
diabetes and their families. Advices should also be given to schools and other venues where 
the children require care when away from home.  At diagnosis the patient and his family must 
be taught survival skills. This includes an explanation of the diagnostic process, what has 
caused the symptoms, the consequences of the disease and the principles of insulin treatment. 
Practical skills (blood and/or urine testing and insulin injections) must be taught and different 
factors in the everyday life, such as food intake, exercise, stress and illness that influence on 
the blood glucose levels, and the thus insulin requirements, must be discussed. Furthermore it 
is crucial that the team educate the family on acute diabetes complications and the treatment 
of these. Initial learning should be reinforced by written guidelines and booklets, and the 
family must receive more thorough education and training when they comprehend and 
manage the basic principles of diabetes and it´s care [46].   
 
Children with diabetes should be seen by a doctor/diabetes care team at least every third 
month. These care visits should include assessment of the child´s general health and well 
being, growth, glycemic control (HbA1c and analysis of home BG records) and treatment 
regiment. A more thorough annual review with greater attention to dietary assessment, 
educational updates and psychosocial needs and laboratory screening, including screening for 
co-morbidities and complications, is also recommended [45].  
 
As children grow both their medical needs and their educational needs change [47]. It is a fine 
balance between giving the child too much and too little independence in the management of 
their diabetes. Therefore the diabetes team, the child and his or her family must continuously 
evaluate the child or adolescent´s needs.  
 
Diabetes self-management education (DSME) is an important factor in reducing HbA1c in 
children with T1D [48]. In a study conducted by a multidisciplinary paediatric diabetes team 
at the Diabetic outpatient department of National Institute of Child Health, Karachi, in 2009, 
60 children with a mean age of 10 years with T1D attended a diabetes self education program 
were they were educated regarding general information about diabetes, basic insulin therapy, 
planning for hypoglycemia, hyperglycemia, activity, travelling and basic nutritional 
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management. Among the 50 children who completed the trial there was a significant decrease 
in HbA1c after the DSME program with a mean pre- and post intervention HbA1c level of 
9.67+/-0.65 and 8.49+/-0.53 respectively (p-value < 0.001) [48].  
5.5.1 Diabetes care in pre-school and school  
Children and adolescents spend approximately half of their waking hours at school. Keeping 
in mind that diabetes is a disease you have to handle at all hours through-out the day diabetes 
support and care at school is essential for the child´s physical and mental health. A child with 
diabetes need special considerations at school including access to and permition to perform 
blood glucose monitoring, free access to bathrooms and drinking water, ability to eat 
anywhere anytime and access to insulin administration. Teachers and other school personnel 
must have knowledge about diabetes and how to administer insulin and treat hypoglycaemias 
and hyperglycaemias. In a study from Florida children with diabetes received inadequate 
diabetes support according to parent reports [49]. They found that many of the children did 
not have written diabetes care plans, especially the Hispanic and black children. Furthermore, 
most children were not allowed to monitor their blood glucose nor inject insulin in class and 
most parents were worried about hypoglycemias and hyperglycemias in school. In another 
study where the children´s perceptions of diabetes support in school was examined, the results 
indicated that the children felt supported at school. However it was concluded that better 
flexibility among teachers and nurses and individualised care plans can improve their ability 
to manage their diabetes better in school [50].  
5.6 Complications  
The most common short term complications and comorbidities among children and 
adolescents with T1D include hypoglycaemia, hyperglycaemia and diabetic ketoacidosis 
(DKA) and psychiatric disorders [51]. Hypoglycaemia in pediatric patients with T1D, is 
usually defined as a blood glucose level below 3.6 mmol/l (<65 mg/dL) [52]. It results from a 
mismatch between insulin dose, food consumed, and recent exercise [52]. Mild 
hypoglycaemia is associated with adrenergic and neuroglycopenic symptoms, such as 
headaches and behavioral changes, and the most severe form is recognized by the precence of 
seizures or coma [53]. DKA is characterized by hyperglycaemia, acidosis and ketonuria and 
results from a combination of absolute or relative insulin deficiency and the effects of counter 
regulatory hormones such as catecholamines, glucagon, cortisol and growth hormone [54]. 
Psychiatric disorders are discussed in the next section (4.7).       
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The pathogenesis of long-term sequelae of T1D, including microvascular (nephropathy, 
neuropathy and retinopathy) and macrovascular complications (cardiovascular disease) begins 
in childhood [53]. The risk of these complications increases with poor glycaemic control and 
duration of diabetes. Although few children and adolescents have clinical evidence of micro- 
or macrovascular complications, at least in developed countries with well-organized diabetes 
care, subclinical findings of vascular disease can be detected. Early detection allows early 
interventions that may reverse the complications or at least delay further progression to 
clinical disease [53]. According to ISPAD guidelines screening programs for 
microalbuminuri, nephropathy, retinopathy and macrovascular disease should be part of the 
diabetes care for all children and adolescents with T1D [55]. 
5.7 Psychosocial issues 
Diabetes is, as a chronic disease, difficult enough to handle for adults. It is even more 
challenging for children and young people as the diabetes interferes with their normal needs 
of childhood and adolescence. This includes the needs to succeed with schoolwork and sports 
and in social networks, and in the challenging transition to adulthood. The DAWN Youth 
initiative is a coordinated, international framework that works on the improvement of 
psychosocial support for children with diabetes internationally [5]. It is a global partnership 
initiative between IDF, ISPAD and Novo Nordisk A/S. The initiative has, through the largest 
study of its kind [5], recognized the great gap between children´s and adolescent´s needs for a 
psychosocial support to deal with their diabetes and what their healthcare system has to offer. 
One third of the patients in the study reported a feeling of “poor well-being” and about half of 
the patients reported a feeling of stress and anxiety due to their diabetes [56]. The initiative 
conclude with the fact that the support for children with diabetes and their families available 
today is far from optimal, even in the most developed countries. Ideally all these families 
should have access to a multidisciplinary team, consisting of a medical and psychosocial 
professional team.  
 
In the ISPAD Consensus Guidelines 2000 it is emphasized that ”Psychosocial factors are the 
most important influences affecting the care and management of diabetes” [57]. Furthermore 
in the guidelines from 2009 ISPAD recommend that social workers and psychologists should 
be a part of the interdisciplinary health care team, that expert help and support from mental 
health professionals should be given young persons or families with overt psychological 
problems and that the diabetes care team should receive training in the recognition, 
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identification and provision of information and counselling on psychological problems related 
to diabetes [58]. 
5.7.1 High rates of psychiatric disorders 
Several studies have found that there is an increased incidence of psychiatric disorders among 
children and adolescents with T1D [59-61]. One prospective longitudinal study found a high 
risk of psychiatric disorders among adolescents with T1D [59]. In this study 37 % of the 41 
adolescents included, met the DSMII criteria for a psychiatric disorder. This is 2-3 times 
higher than community levels of psychiatric disorders [59]. Furthermore, they found that 
there was an association between a history of poor controlled diabetes in the first 10 years 
after diagnosis and pre-existing behaviour problems. And this again was associated with 
increased risk of psychiatric disorders [59]. In another study from the Netherlands, 17.2% of 
the persons in a group of 233 youth between 9 and 19 years with T1D reported elevated 
depressive symptoms on the Child Depression Inventory. Of these, 28% received 
psychological care, 25 % wished to see a psychologist and 47% did not think it was 
necessary. Furthermore they found that only half of the youth talked to their doctor or nurse 
about their feelings. Their conclusion is that screening for depressive symptoms in the context 
of outpatient consultations can improve early detection and treatment of emotional problems 
[62].  
5.7.2 Eating disorders among adolescents with type 1 diabetes 
The prevalence of eating-disorders is significantly higher among adolescents with T1D than 
among non-diabetic teenagers [63, 64]. Potential risk factors for developing eating disorders 
that have been identified are among others; female gender [63], increased body weight, 
partially caused by insulin therapy, that lead to body dissatisfaction [64], difficulties with 
adapting to the hormonal and psychoemotional changes associated with puberty [65], a 
constant food preoccupation because of the diabetes [64, 66], problems with family 
relationships [63] and other psychiatric disorders, including depression and substance abuse 
[67].  
 
An important complication in children and adolescents with diabetes and an eating disorder is 
poor glycaemic control and increased risk of frequent episodes of DKA [68]. Eating disorder 
is a severe disease; even more severe in adolescents with diabetes, and early diagnosis with 
screening programmes during the prepubertal period is important [69].  
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5.7.3 Fear of hypoglycemias 
Several studies have shown that parents of children with diabetes show a significant fear of 
hypoglycaemias [70, 71], especially if the child has experienced a hypoglycaemic convulsion 
[72]. This fear may be a barrier for optimal glycaemic control, because a the parents might 
rather let the child run their blood glucose level higher than recommended to reduce the risk 
of development of hypoglycaemias.  
 
In a field study from Virginia on children between 6 and 11 years and their parents, it was 
found that parents and children´s ability to recognize hypoglycaemias is a significant problem 
[73]. This again can be a risk factor for episodes of severe hypoglycaemia. More education 
and training for the children and their families to detect hypoglycaemias is needed.  
5.7.4 Mental health screening 
In a review article from 2007 the authors argue that mental health should be given 
equivalence to, or even precedence over, other complication screenings done in diabetes 
clinics [74]. They refer to several studies that have showed disturbingly high rates of 
psychological problems [59-61, 75], and that the problems are likely to persist into early 
adulthood [59, 76-79]. They conclude that complication-screening programs should include a 
mental health component from the time of diagnosis. Furthermore, they emphasise that 
considerations should be given to simplify screening of the rare micro vascular and 
autoimmune disorders to release resources for the more common psychiatric disorders [74]. In 
a randomized controlled trial from the Netherlands, periodic monitoring and discussion about 
health-related quality of life was proven to be appreciated by adolescents with T1D [80]. 
After a 12-month follow-up, patients in the intervention group reported improved self-esteem 
and mental health, significantly fewer behavioural problems and participated more in family 
activities.  The adolescents in this study had relatively high levels of well-being prior the 
study, so further similar trials need to be conducted to see if improvements can be achieved in 
teenagers with lower levels of well being as well [80].  
5.7.5 Treatment regimens, HbA1c and Quality of Life 
In a large international multi-language study evaluating the relationship between metabolic 
control and Quality-of-Life (QoL) in adolescents with diabetes, they found that better 
metabolic control was associated with a better QoL [81]. They also suggested that since 
people with higher QoL may be better equipped both physically and psychologically to 
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handle the burdens of their diabetes management, a better QoL may also facilitate improved 
self-care and thus better metabolic control.  
 
In another study conducted by the Hvideroe group, it was investigated whether differences in 
insulin treatment was associated with different outcomes in metabolic control among 
adolescent patients with T1D [82]. No improvement in HbA1c was observed even among the 
adolescent who changed from twice daily to multiple injections, indicating that insulin 
treatment is only one aspect of the diabetes treatment, and other factors such as attitudes of 
the treatment team, self care behavior, education models and patient satisfaction may be more 
directly related to the outcomes than the insulin regiments. 
 
A systematic review and meta-analysis of randomised controlled trials on ”psychosocial 
outcomes following education, self-management and psychological interventions in diabetes 
mellitus”, concluded that psychological treatment can slightly improve glycaemic control in 
children and adolescents with diabetes [83]  
5.7.6 Parental burnout 
When a child is diagnosed with diabetes a whole family is affected. Some families cope very 
well others do not cope at all. In Sweden 252 parents of children with T1D answered a self-
report questionnaire that assessed symptoms of parental burnout and background factors [84]. 
They found that parental burnout was associated with low social support, lack of leisure time, 
financial concerns and a perception that the child´s disease affects everyday life [84]. There 
was no association between sociodemographic or medical factors and burnout. The Quality of 
Life study conducted by the Hvideroe group showed an impact of family structure and 
ethnicity on QoL [81]. 
 
It is important to recognize the parent’s attitudes and concerns associated with their child´s 
diabetes, but also other factors in the everyday life that might make things extra challenging. 
Several studies have shown that parents of children with diabetes experience greater levels of 
stress than parents of healthy children [85, 86]  
 
A diabetes-specific questionnaire on parent´s quality of life and satisfaction with their child´s 
diabetes treatment, the Well-being and Satisfaction of CAREgivers of Children with Diabetes 
Questionnaire (WE-CARE) was developed in the United States in 2007 [87]. A psychometric 
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validation was conducted (parents of 116 children with T1D aged 6-11 years were included) 
and the data suggested that WE-CARE provides a reliable and valid measure of parent´s well-
being and satisfaction with the treatment related to their child with diabetes [87].  
 
The parent’s perceptions of the child’s treatment will necessarily have significant impact on 
their own well-being, and also the child´s well-being. Furthermore this might affect the 
child´s compliance, glycaemic control and quality of life. In a recent study from the USA 
where parents of children with T1D received either group-based educational training, or 
group-based coping skills training the findings suggested that group-based intervention in 
general may improve the parents coping and their quality of life [88].  
5.8 Guidelines 
5.8.1 ISPAD  guidelines 
ISPAD work to promote ”optimal health, social welfare and quality of life for all children 
with diabetes around the world”.  The new and enriched edition of the Clinical Practice 
Consensus Guidelines from 2009 is based on a wide consensus of clinical practice. The 
guidelines have been modified by experts in different specialities around the world, debated at 
annual ISPAD meetings and reviewed by the ISPAD members [89], and are now used in 
many countries in the daily care of patients with diabetes. 
 
In Norway the ISPAD guidelines are followed.  
5.8.2 Australian guidelines 
In Australia the management of children with diabetes is based on the Australian Clinical 
Practical Guidelines: T1D in Children and Adolescents prepared by the Australasian 
Paediatric Endocrine Group for the Department of Health and Aging. The guidelines were 
published in 1996 and updated with an evidence-based approach by a national 
multidisciplinary writing committee, and approved in 2005 [90]. When developing the latter 
version, other guidelines, position papers and technical reports regarding the management of 
T1D in children and adolescents were sought from the World Health Organization (WHO), 
International Diabetes Federation (IDF), American Diabetes Association (ADA), National 
Health and Medical Research Council (NHMRC), Australian Paediatric Endocrine Group 
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(APEG), ISPAD, National Institute of Clinical Excellence (NICE) guideline on T1D and 
more.  
 
Related to the subjects of this thesis there are no major differences between the ISPAD and 
the APEG guidelines, thus including a thorough comparison in this paper was not found to be 
necessary.  
5.9 Diabetes Databases 
Norway and Australia both have prospective, population based national diabetes registers.  
 
In Norway there is a particular register for diabetes in children; The Norwegian Childhood 
Diabetes Registry (NCDR). The register is based on The Norwegian Study Group of 
Childhood Diabetes, which is a network of all paediatricians treating diabetes in Norway. The 
patients and their parents have to consent to be included in the registry. NCDR was 
established in 2006. It includes data on childhood diabetes incidence since 1989 and annual 
data on the quality of care since 2000. In addition the incidence of complications is 
documented [12]. All data is valid and ethically improved. 
 
In Australia the database is called The National Diabetes Register (NDR). It collects 
information about people who use insulin in the treatment of their diabetes. Persons with 
T1D, T2D and gestational diabetes who started to use insulin after the 1st of January 1999 and 
have consented to be a part of the database are included. The Register obtains information 
from two main data sources, 1) the National Diabetes Service Scheme, administered by 
Diabetes Australia and from 2) the Australasian Paediatric Endocrine Group (APEG) state 
based register. The latter register collects information about persons with diabetes under the 
age of 15. All reports on incidence and information on epidemiological and clinical studies in 
NDR are valid and ethically improved [91].  
 
5.10 National Diabetes Organisations 
In Norway there is a national diabetes organisation called Diabetesforbundet. It is divided 
into 137 smaller local departments and has a total of more than 40 000 members [92]. A 
membership includes access to magazines on diabetes, courses, educational programs, social 
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happenings, summer camps, reduced prizes on diabetes products, advocacy help and online 
resources including a webpage for young people with diabetes.  
 
Diabetes Australia is Australia’s National Diabetes organisation [93]. The organisation is 
divided into departments in each state; Diabetes Australia-Victoria, Diabetes Australia-New 
South Wales, Healthy Living Northern Territory etc. A membership in Diabetes Australia 
includes access to updated information and magazines on diabetes (special magazines for 
children and teenagers), courses, educational programs, supermarket tours, telephone support 
(Diabetes Info Line), Advocacy Officer, reduced prizes on diabetes products, cheaper travels, 
health insurance and some diabetes services, camps for young people, support groups and 
online resources.   
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6 PART TWO – The clinical part  
6.1 Results and personal experiences 
This part contains results from a comparison on the management of T1D in children and 
adolecents at hospitals in three states in Australia and the capitol of Norway. My personal 
experiences from participation in outpatient appointments, educations sessions etc. is included 
here. 
6.1.1 Presentation of the four visited hospitals 
6.1.1.1 Oslo  
I visited the children´s clinic at Oslo University Hospital (OUH) in 2009 prior my departure 
to Australia. The local informants helping me to fill out the questionnaire were Diabetes 
Nurse Siv Janne Kummernes and Senior Consultant Torild Skrivarhaug, MD. 
6.1.1.2 Melbourne  
The Royal Children´s hospital (RCH) [94], in Melbourne was visited in October and 
November 2009. During my clinical rotation here I participated in the daily work with 
children and adolescents with T1D.  Diabetes Educator Andrew Boucher, the Allied Health 
Team (diabetes team) and Professor Fergus Cameron were interviewed. 
Oslo University Hospital, Oslo, Norway 
OUH is placed in Oslo, the capitol of Norway. The paediatric department at OUH, 
including a 22-bed children´s ward and an outpatient clinic, is the largest for children with 
diabetes in Norway. It covers a considerable area in the southeast of Norway; Oslo, Asker 
and Bærum.  More than 300 children with diabetes are followed up here (Table 7).  
The Royal Children´s Hospital (RCH) in Melbourne, Victoria, Australia 
The Royal Children´s Hospital is placed in Melbourne, the state capitol of Victoria. It is 
the major specialist paediatric hospital in Victoria and is internationally recognized as a 
leading centre of paediatric treatment, teaching and research. RCH care for children from 
Victoria, Tasmania, southern New South Wales and other states around Australia and 
overseas. Admissions for diabetes go to the children´s medical ward (32/33 beds) and the 
adolescent ward (20/22 beds). Approximately 1500 children with Type 1 Diabetes are 
followed up at RCH, in addition 200 children outreach in regional centres (Table 7).  
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6.1.1.3 Alice Springs 
After my stay at RCH in Melbourne I went to Alice Springs Hospital [95-97]), placed in the 
centre of Australia. Local informants here were Diabetes Educator Glynis Dent and Dr. Rose 
Fahy  
6.1.1.4 Newcastle 
John Hunter Hospital (JHH) [98], in Newcastle, New South Wales, Australia, was visited in 
2010. The local informant here was Professor Patricia Crock. 
 
 
Alice Springs Hospital, Alice Springs. Northern Territory, Australia. 
ASH is a 189-bed specialist teaching hospital situated in the Red Centre of Australia. The 
population (55 000 people) in the middle of Australia is dispersed over 1.6 million square 
kilometres. Approximately 60 % of the patients admitted to ASH are aboriginal. Statistics 
indicate that Aboriginal patients remain in hospital, on average, longer than non-
Aboriginal patients and occupy approximately 80% of occupied bed days at any time. 
English is often a second, third or fourth language among the aboriginal patients and team 
of Aboriginal Liaison Officers assist the patient management by providing interpretation 
services and social, emotional and cultural support.  
The hospital has a children´s ward with 40 beds and an out-patient clinic. 8 children with 
T1D are followed up at ASH (Table 7). 
John Hunter Hospital, Newcastle. New South Wales, Australia 
John Hunter Hospital is placed in Newcastle, NSW´s second largest city after Sydney. 
The hospital houses one of the three designated children´s hospitals in NSW, providing 
health care for children up to 18 years of age from the Hunter New England Health 
region and other parts of northern NSW. There are a total of 110 beds in the paediatric 
part of JHH. This includes 41 beds in the Neonatal Intensive Care Unit, 14 beds in Day-
Stay, 19 beds in the surgical ward, 24 beds in the children´s medical ward and 12 beds in 
the adolescent ward. Approximately 360 children and adolescents are followed up at JHH 
(Table 7). This number includes teenagers between 15 and 18 years.   
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6.1.2 Hospital admissions 
Type 1 diabetes 
In 2007, 27 children younger than 18 years of age were admitted to OUH with a new 
diagnosis of T1D. In 2009 the number of newly diagnosed was 35. At RCH the annual 
number of newly diagnosed children in the same age group is 130-150. Another 50-60 
children with known T1D, are each year admitted for stabilisation. The number of T1D 
admissions is a lot smaller at ASH, which is placed in the Australian state with the lowest 
incidence rate of T1D among young people (Table 2c). In year 2000 only one child was 
diagnosed with T1D at this hospital. The year after ASH had 11 T1D admissions. Five of 
these admissions were the same child. In 2008 four children with T1D were admitted, where 
of two were newly diagnosed and two were readmissions [99]. Approximately 220 children 
with T1D are admitted to JHH annually. The admissions include children with newly 
diagnosed diabetes, readmissions for stabilization and pump starters (Table 5). 
 
Table 5: Annual hospital admissions among children with type 1 diabetes < 15 years at 
one hospital in Oslo, Norway and hospitals in three different states in Australia. The 
numbers (approximates) include newly diagnosed, readmissions and pump starters.  
 
Oslo 
University 
Hospital, 
Oslo  
Royal 
Children´s 
Hospital, 
Melbourne, 
Victoria 
Alice Springs 
Hospital, Alice 
Springs, Northern 
Territory 
John Hunter 
Hospital, 
Newcastle, 
New South 
Wales 
Children with T1D 
< 18 years admitted 
to the hospitals 
annually (2007-08) 
27-35 newly 
diagnosed 
130-150 newly 
diagnosed and 
another 50-60 
admissions for 
stabilisation 
Depends; between 1 
and 11 admissions 
between 1999 and 2008 
Approx. 220 
Children followed 
up at the hospitals 
(per 2009) 303 1500 * 8 363 
• * The endocrinologists at RCH care for an additional 200 patients in regional centres (Outreach) 
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Type 2 Diabetes 
Although once considered as a disease of adults, the prevalence of Type 2 Diabetes (T2D) is 
also increasing among children and adolescents worldwide [100]. All the hospitals I have 
visited also care for a few adolescents with T2D. During my stay at RCH I met two teenage 
girls (11 and 13 years old) with T2D. They both had extremely bad compliance with a very 
high BMI and HbA1c. What characterized these two young girls was inactivity and unhealthy 
food intake. Even during their stay at the hospital they ordered fast food. The girls where 
admitted for several days for re-education and stabilization because of their high HbA1c 
levels. During my 6 weeks at the children´s ward at ASH I did not meet any children with 
T1D. However, I met a teenage girl admitted for stabilization of her badly controlled T2D. 
Her characteristics were similar to the girls with T2D I met at RCH. 
6.1.3 Time of diagnosis 
All the presented hospitals adhere to national guidelines based on the ISPAD guidelines 
(Table 3) for the diagnosis of T1D. The diagnosis of T1D is always made/confirmed by 
specialized health services. This rule applies to all the visited hospitals (Table 6).  
 
Oslo University Hospital 
At OUH the patients are usually sent from their general practitioner (GP) who strongly 
suspect the diagnosis of diabetes. When diabetes is confirmed, the child is admitted (always) 
and the initial diabetes treatment and education is commenced. The average length of stay at 
diabetes onset is 11 days (Table 6). It varies between 6 and 14 days, depending on the 
presentation, the child´s age, the family etc. A diabetes doctor and ward nurses are 
responsible for the initial treatment. Within the first days the child and family meet the whole 
diabetes team, consisting of diabetes nurses, a dietician, a social worker and a psychologist. 
Interpreters are available. 
 
Royal Children´s Hospital 
Many children are diagnosed with diabetes in general practice and then referred to RCH, 
where the diagnosis must be confirmed. Most often the child is then admitted for the initial 
treatment and education. A paediatrician and the diabetes team are responsible for the initial 
treatment. The average time of stay at the hospital at diabetes onset is 4 days (Table 6). 
However, some patients are not admitted. In the Australian guidelines it is emphasized that in 
appropriately chosen patients there are “no disadvantages of ambulatory management compared 
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to inpatient management of children and adolescents with newly diagnosed T1D” [90]. 
Depending on the child´s age, the clinical status and how the child and family copes with the 
new diagnosis, a decision is made by the diabetes team and the family whether admission or 
out-patient treatment is the best choice in the acute phase. In some cases the diabetes team 
visits the family at their home place to inject insulin and to educate the family the first few 
days. All children under the age of 2 years must be admitted. This is also the case if the 
family lives more than 30 km from RCH or if they live closer but do not have a car. 
Furthermore, if the family needs an interpreter admission is necessary. 
 
Alice Springs Hospital 
In the Red Centre of Australia diabetes is very often randomly diagnosed in a child that 
comes to the emergency department with a viral infection, for example a urinary tract 
infection. The blood glucose is usually very high and the child is ketotic at investigations.  
When the family is asked specific about polyuria and polydipsia they confirm that this has 
been a problem the last days or weeks prior hospitalization.  This might implicate that the 
people living in Central Australia are not well enough informed about symptoms of T1D. 
Lower incidence of T1D in NT compared to other parts of Australia, language problems 
among the aboriginal population and the fact that the population is dispersed over a large area, 
could be some of the reasons for this. A diagnosis of diabetes always leads to admission. A 
paediatrician is responsible for the initial treatment. The average length of stay is between 3 
and 5 days (Table 6), depending on the child´s age, family situation etc. A lot of families stay 
up to 10 days at the children´s ward. If the family need an interpreter during their stay, this 
can be organized.  
 
John Hunter Hospital 
Most often children are diagnosed with T1D in general practice and then referred to JHH for 
confirmation of the diagnosis, initial treatment and education. A paediatrician and diabetes 
educators from the specialised diabetes team are responsible for this. The child is then 
admitted (always). The average length of stay at diagnosis is four-five days (Table 6). 
Interpreters are always available.  
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6.1.4 Diabetic ketoacidosis (DKA) at diagnosis 
The ISPAD criterias for DKA are adhered to at all the visited hospitals (Table 6).  
 
The ISPAD diagnostic biochemical criteria for DKA [101]: 
 
 
 
 
 
 
Approximately 25% of the children admitted to OUH with a new diagnosis of T1D have 
DKA at the time of diagnosis. Almost the same amount of children, approximately 28%, has 
DKA at the time of diagnosis at RCH. At ASH and JHH the number is unknown (Table 6). 
 
Table 6: At diabetes onset the diagnostic criteria for type 1 diabetes used at one hospital 
in Oslo, Norway and three hospitals in three different states in Australia  
	   Oslo	  University	  
Hospital,	  Oslo	  	  
Royal	  Children´s	  
Hospital,	  
Melbourne,	  
Victoria	  
Alice	  Springs	  
Hospital,	  Alice	  
Springs,	  
Northern	  
Territory	  
John	  Hunter	  
Hospital,	  Newcastle,	  
New	  South	  Wales	  
Diagnostic	  criteria	  
for	  T1D	  
National 
guidelines based 
on ISPAD 
APEG and 
ISPAD 
APEG and 
ISPAD 
APEG and ISPAD 
Confirmation	  of	  
diagnosis	  
Specialized 
health service 
Specialized 
health service 
Specialized 
health service 
Specialized health 
service 
Number	  of	  children	  
with	  DKA	  at	  time	  of	  
diagnosis	  
	  
25% 28% ? ? 
Diagnostic	  criteria	  
for	  DKA	  
	  
ISPAD criteria ISPAD criteria ISPAD criteria ISPAD criteria 
• Hyperglycemia (blood glucose > 11 mmol/L 
[200mg/dL]) 
• Venous pH < 7.3 or bicarbonate < 15 mmol/L 
• Ketonemia and ketonuria 
 
Mild DKA: venous pH <  7.3 
or bicarbonate < 15 mmol/L 
Moderate DKA: pH <  7.2, 
bicarbonate < 10 mmol/L 
Severe DKA: pH <  7.1, 
bicarbonate < 5 mmol/L 
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   Oslo	  University	  
Hospital,	  Oslo	  	  
Royal	  Children´s	  
Hospital,	  
Melbourne,	  
Victoria	  
Alice	  Springs	  
Hospital,	  Alice	  
Springs,	  
Northern	  
Territory	  
John	  Hunter	  
Hospital,	  Newcastle,	  
New	  South	  Wales	  
Admission	  to	  the	  
hospital	  when	  
newly	  diagnosed	  
Yes Yes 
  
Yes Yes 
Average	  time	  of	  
stay	  at	  the	  hospital	  
11 days  4 days 6-7 days  4-5 days 
6.1.5 Adolescent ward 
There is no adolescent ward at OUH, ASH or JHH, and young people with diabetes are 
therefore usually followed up at the Children´s Department until they turn 18 years old. 
At RCH, on the other hand, there is an adolescent ward. Adolescents diagnosed with T1D are 
admitted to this ward, but there are no special adolescent endocrinologists there. The 
paediatricians and the diabetes allied health team at the hospital, consequently manage both 
children and adolescents with diabetes. However, adolescents and young adults can be 
followed up at special adolescent clinics outside the hospitals in the intermediate period 
between paediatric management and adult medicine management.   
6.1.6 Treatment regimens 
Oslo University Hospital 
In Norway the most common treatment regimens for children of all ages are insulin pump and 
multi-injection therapy. The preferred regimens for toddlers and youngsters in Norway are 
insulin pump therapy. At OUH toddlers and young children are routinely started on insulin 
pump treatment when diagnosed with T1D. Older children and teenagers are either on the 
pump (~ 60%) or on multi-injection therapy (~ 40%).  Twice-daily insulin treatment is hardly 
ever used at OUH (Table 7). 
 
Royal Children´s Hospital 
RCH think somewhat differently when it comes to treatment regimens. Most toddlers and 
young children followed up here are treated with twice daily insulin injections (50%). The 
injections are usually given before breakfast and dinner, and consist of a combination of short 
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or rapid-acting insulin and intermediate-acting insulin. The rationale behind this choice of 
treatment for the youngest children is to avoid focus on diabetes when they are at pre-school 
or school.  Most schools do not have school nurses to help with insulin administration making 
it difficult for the youngsters to take their injections. Furthermore, a young child has a quite 
regular schedule when it comes to meals and amount of activity. Therefore the diabetes team 
at RCH believe that administration of insulin twice daily combined with a planned and 
balanced diet is optimal for the youngest children. However, when they reach their teenage 
years and their blood glucose levels become more difficult to control with this regime, multi-
injection therapy is commenced. At RCH approximately 20% of the total patient population 
are on multi-injection therapy and 30% are on the insulin pump (Table 7). A lot of questions 
are raised when insulin pump is discussed at RCH. One important issue is “Who is 
responsible to control the pump at school/playgroup?” Another issue is cost. It is a very 
expensive regime in Australia, and almost impossible for a family to afford it without private 
health insurance. This takes time. The child needs to have the private health insurance one 
year prior applying for the pump. 
 
Alice Springs Hospital 
All children are started on twice-daily injections at ASH, which is the only treatment regime 
used at this hospital (Table 7).  
 
John Hunter Hospital 
Since 2004 the endocrinologists at JHH have recommended their patients to use multi-
injection therapy or insulin pump. For patients using multiple daily injections (MDI) they 
have developed a Bolus Card Calculator, called ezy-BICC, to help determine the amount of 
rapid-acting insulin to inject before meals. The patients use their current blood glucose level 
(BGL) and their planned intake of carbohydrate exchanges to read the insulin dose from the 
individualized table on the ezy-BICC.  The values in the table depend on the following 
variables: carbohydrate ratio, correction ratio, target BGL, a low BGL and carbohydrate 
discounted in the calculation if the BGL falls below this value. In a study between year 2000 
and 2006 comparing young patients on MDI using ezy-BICC, with young patients on mixed 
insulin and insulin pump, they found that the patients on ezy-BICC and on insulin pump 
achieved lower HbA1c than those on mixed insulin[102]. Very young patients achieved 
excellent HbA1c using the pump, but for 12-20 years olds the ezy-BICC resulted in lower 
HbA1c than the pump for a lower cost [102]. The ezy-BICC system is inexpensive and 
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convenient and allows patients to vary meal size. Per December 2010, 52% are on this 
regime, 38% on insulin pump, 3.7% on fix dose MDI and 6% on conventional (two or three 
times daily) insulin treatment (Table 7). 
 
Table 7: Proportion of children with type 1 diabetes on different treatment regiments at 
Oslo University Hospital (OUH) in Oslo, Norway* and Royal Children´s Hospital 
(RCH) in Melbourne, Australia, Alice Springs Hospital (ASH) in Alice Springs, 
Australia and John Hunter Hospital (JHH) in Newcastle, Australia (approximates). 
Numbers are from 2008.  
 
*The only hospital in Oslo that treat children with diabetes 
6.1.7 Carbohydrate counting 
At all the four hospitals carbohydrate counting is used systematically when calculating the 
insulin boluses in relation to food.  Many children in Norway and Australia have smart-
telephones, and an application for carb-counting is available on the Internet to download.  
6.1.8 Treatment goals and average HbA1c 
The treatment goal at OUH, RCH and ASH is HbA1c less than 7,5% (Table 8). Few children 
reach this goal. At OUH approximately 24 % of the young patients with T1D have HbA1c 
less than 7,5%.  At RCH approx. 30% reach the goal. The number is unknown at ASH, but at 
least 50% do not reach the goal. At JHH the treatment goal is slightly stricter. They target all 
their T1D children to have HbA1c < 7% (Table 8). The percentage of children who reach this 
goal is unknown. IN 2008, the average HbA1c in Norway and Australia is 8,6% and 8,4% 
respectively. 
 
 
0	  %	  20	  %	  
40	  %	  60	  %	  
80	  %	  100	  %	  
120	  %	  
OUH	   RCH	   ASH	   JHH	  
Twice	  daily	  insulin	  injection	  Multiinjection	  therapy	  insulin	  pump	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Table 8: The treatment goals (HbA1c) and average HbA1c in 2008 among children and 
adolescents with Type 1 Diabetes in Norway and Australia.  
 NORWAY* AUSTRALIA** OUS, 
Oslo, 
Norway 
RCH, 
Victoria 
ASH, 
Northern 
Territory 
JHH,  
New 
South 
Wales 
Treatment 
goal-
HbA1c 
< 7.5% < 7.5% < 7,5 % < 7.5% < 7.5% < 7 %  
Average 
HbA1c 
8.6%  8.4%   8,7% 8.1%  Unknown Unknown 
The numbers are collected from 2008 and are collected from the Norwegian Childhood Diabetes 
Registry* and the APEG Register in Australia**. 
6.1.9 Multidisciplinary team 
Oslo University Hospital 
In the Norwegian National strategy for diabetes from 2006-2010 the establishment and 
strengthening of diabetes teams in the management of persons with diabetes was emphasized.  
[103]. At paediatric departments in Norway the multidisciplinary teams should consist of one 
fulltime diabetes nurse/educator per 100 patients at the outpatient clinic, one or two nurses 
with knowledge about diabetes at the ward, one or two consultant doctors with interest in 
diabetes or paediatric endocrinologists, one doctor in learning/registrar, one dietician in a 
minimum of 50% position, one social worker in a minimum of 20% position and one 
psychologist in a minimum of 40% position. In addition a bioengineer and a pharmacist 
should be attached to the team as consultants [104]. OUH have managed to compose such a 
multidisciplinary team responsible for the management of children with T1D. The team 
consists of doctors with a special interest in children with diabetes, diabetes nurses, a social 
worker in a part time position (40%), a dietician in a part time position (40%), and a 
psychologist in a part time position (50%) (Table 9).  
 
Royal Children´s Hospital 
At RCH in Melbourne the diabetes team is also highly qualified, consisting of paediatric 
endocrinologists (three consultants and four registrars), five diabetes nurse educators, two 
dieticians working part-time in the team (75%) and two social workers (Table 9). Although 
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this is a multidisciplinary team, the lack of a psychiatrist or a psychologist is an important 
issue. The team at RCH have been working towards the engagement of a mental health 
worker on a permanent basis, but it is a matter of financial constraints. Today psychologists 
are involved only if the children have psychological issues in addition to the common mental 
health issues that are raised when having a chronic illness like diabetes. 
 
Alice Springs Hospital 
Because there are very few children and adolescents with diabetes at ASH, the hospital does 
not have a multidisciplinary team like RCH or OUH. Nevertheless, whenever there is a child 
who is admitted with diabetes, and when children and adolescents visit the outpatient clinic 
for their check-ups, the paediatricians, the diabetes educator and a dietician at the hospital 
work together as a functional team (Table 9). If the family is aboriginal, an aboriginal liaison 
officer (ALO) is also included. The ALO can provide emotional, social and cultural support 
to the patients and their families, liaison services and information about hospital services and 
the linkage between the hospital and the indigenous community resources. A diabetes 
educator from Healthy Living NT (Diabetes Australia) also engages in the management of 
children diagnosed with T1D at ASH.  
 
John Hunter Hospital 
At JHH a multidisciplinary team, like the ones at OUH and RCH, is responsible for the 
management of children with T1D. The team consist of three paediatric endocrinologist, three 
credential diabetes educators, one social worker and one dietician in a 70 % 
employment/position (Table 9). Each child has one particular doctor.  The need for a 
psychologist on the team is recognized, but it is, as for RCH, a cost issue at the moment.  
 
The diabetes teams available for children and adolescents with T1D in Norway and Australia 
also care for the children wit T2D. No separate teams for young patients with T2D are 
available.  
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Table 9: Members of the diabetes teams at one hospital in Oslo, Norway and three 
hospitals in three different states in Australia 
 
Oslo 
University 
Hospital, 
Oslo  
Royal Children´s 
Hospital, 
Melbourne, 
Victoria 
Alice Springs 
Hospital, Alice 
Springs, 
Northern 
Territory 
John Hunter 
Hospital, 
Newcastle, New 
South Wales 
Doctor 4 7* 1 (2) 3 
Nurse/credential 
diabetes educator 
2.3 5 1  3 
Dietician 0.4 1.5 1 0.7 
Social worker 0.4 2 0** 1 
Psychologist 0.5 0*** 0*** 0*** 
Other   1****  
• * 3 Consultants and 4 Registrars 
• ** only if there are family issues 
• ***Available on request 
• **** Aboriginal Liaison Officer and GP 
 
6.1.10 Follow up and Management – Diabetes Clinics 
Oslo University Hospital 
OUH aim to give every child with diabetes a primary doctor. The child is seen by this doctor 
every third month in the paediatric outpatient clinic (Table 10). Sometimes consultations 
every six weeks is necessary, and extra consultations with a diabetes nurse are often offered in 
addition to the doctor´s appointments. At every consultation the doctor and the child/family 
study the child´s diabetes diary and talk about concerns, what´s going good and what´s going 
not so good. The child´s HbA1c is measured, growth and development is monitored and an 
examination to look for fatty lumps (lipohypertrophy) is always included. Most children 
attend their appointments. In addition to the check-ups, the child and family can call the 
diabetes team anytime for advice and to arrange extra consultations.   
 
Royal Children´s Hospital 
At RCH in Melbourne all the consultations for children with T1D are organised in special 
diabetes clinics. The consultations take place twice a week; Wednesday and Thursday 
afternoons in the outpatient clinic. The clinics run from three - five pm, and are exclusively 
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for children and adolescents with diabetes. The children with and their families are seen every 
third month on these days (Table 10). On arrival, approximately 30 minutes before their 
doctor’s appointment, the children are measured and weighed, and a blood sample is taken. 
By the time they are seen by their doctor, the HbA1c result is ready and can be discussed in 
the consultation. In the meantime, while waiting for their appointment, the diabetes nurse 
educators and dieticians from the diabetes team, talk to the families. In this way the families 
can easily book appointments if the family, child or the educators or dieticians find it 
necessary with additional education sessions or nutritional advice.  
 
At every consultation, the doctor and the child/family study the child´s diabetes diary and talk 
about concerns, what´s going good and what´s going not so good. The child’s height and 
weight is plotted on a growth chart, the HbA1c is discussed and an examination to look for 
fatty lumps (lipohypertrophy) is performed. Most children attend their appointments. 
 
The members of the diabetes teams are always available for telephone consultations and 
problem-solving assistance. 
 
Alice Springs Hospital 
Although there are few children with diabetes who are followed up at ASH, the paediatric 
team try their best to adhere to the ISPAD and the APEG guidelines. A general, a 
paediatrician at ASH is responsible for the treatment of the child. Sometimes an 
endocrinologist (not a paediatric endocrinologist) is involved too. The child and family visit 
the hospital for the doctor’s check-ups every third or six months (Table 10). They all have 
their consultant doctor´s phone number and can contact him or her if they need advice or 
support. Furthermore, a community diabetes educator from Healthy Living NT (Diabetes 
Australia in NT) is also involved in the management of children with diabetes in the area 
around Alice Springs and in the community. Only 50-75% of T1D at patients attend their 
appointments at ASH. The compliance is very low amongst aboriginals, but also amongst 
caucasian teenagers.  
  
John Hunter Hospital 
At JHH the children are followed up by their endocrinologist and the diabetes team every 
third month, or every second month for toddlers (Table 10). At each consultation the doctor 
and the child/family study the child´s diabetes diary and talk about concerns, what´s going 
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good and what´s going not so good.  Their HbA1c, height, weight and abdominal 
circumference is measured.  The BMI is noted and the child is examined to look for fatty 
lumps (lipohypertrophy).  Most children attend their appointments.  
 
If a child has HbA1c > 10% at two successive check-ups, he or she is admitted for 
stabilization immediately. At one outpatient clinic I observed that 2 children with HbA1c of 
12% and 10,4% had to be admitted for stabilization.  
 
Table 10: Frequency of diabetes check-ups at one hospital in Oslo, Norway and three 
hospitals in three different states in Australia 
 
6.1.11 Education  
Oslo University Hospital  
The whole multidisciplinary team is responsible for educating the child with diabetes and his 
or her family. Group teaching is not practiced. The child´s doctor and the nurses in the team 
are the main responsible for the education, but the rest of the team is also involved in the 
education, from the time of diagnosis. A thorough education program is fulfilled in the period 
immediately after the child is diagnosed, based on the ISPAD guidelines. Further education is 
done at each check-up. In addition to educating the child and family, the diabetes nurses offer 
to visit the child´s school or nursery, soon after the child has been diagnosed, to educate the 
teachers or caretakers about diabetes. From third grade some basic diabetes education is also 
given the pupils in the child´s class.  
 
 
 
Oslo University 
Hospital, Oslo  
Royal 
Children´s 
Hospital, 
Melbourne, 
Victoria 
Alice Springs 
Hospital, Alice 
Springs, 
Northern 
Territory 
 
John Hunter 
Hospital, 
Newcastle, New 
South Wales 
Check-ups 
3 monthly, 
sometimes more 
often 
3 monthly, 
sometimes 
every 6 weeks 
3 or 6 monthly 
3 monthly 
 
2 monthly for 
toddlers 
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Royal Children´s Hospital 
Also at RCH the doctor(s) treating the child, and the diabetes team are responsible for 
educating the child and family. On request a psychologist and/or school nurse can get 
involved. At the time of diagnosis the family goes through an intensive education program 
with the diabetes educators and the dieticians. This happens individually as for the families at 
OUH. They also get advice and information from the paediatrician and the social worker. The 
family receive a lot of papers and information compendiums. After thorough education 
lessons the family and child complete a Diabetes Care Quiz. This is mainly to discover areas 
that are not explained well enough in the education sessions.  
 
Schoolteachers and caretakers at nurseries are offered to come to school seminars arranged at 
RCH, to learn the basics about T1D in young people. 
 
Alice Springs Hospital 
At ASH the child and family are educated individually at the hospital in the first days 
following the diagnosis.  The three important tasks the child and family must manage before 
they are discharged are blood glucose management, insulin injections and hypoglycaemia 
management. The teachers at the child´s school or nursery are educated through Healthy 
Living NT (Diabetes Australia). 
 
John Hunter Hospital 
All education is organised individually at JHH, not in 
groups with other families of children with diabetes. In 
addition to the child with newly diagnosed diabetes and 
the closest family, education is also offered 
grandparents, the nursery and school. Among other 
things the team try to arrange school visits, where the 
child´s teacher receives a school kit (Picture 1) with 
information on T1D in general and in association with 
the child. This task is both time and staff demanding, 
and although the team wish to accomplish this for all 
the children it has to target and prioritize the higher risk 
patients, e.g. toddlers on pump.  
Picture 1: Information brochure from the school kit 
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6.1.12 Re-education  
I witnessed the importance of re-education several times during clinical work on this thesis.  
Both children and parents easily forget and omit important tasks in the management of their 
condition. My impression is that the families manage the treatment of diabetes more 
appropriate when they are reminded once in a while what diabetes does to the child’s body, 
how insulin works on the cells and why good glucose control is essential, not only to reduce 
the risks of late complications but also to optimize the daily quality of life. 
 
Oslo University Hospital 
At OUH all children with diabetes are invited to re-education when they turn 12 years. The 
re-education is organized in groups. In addition extra education is offered when the doctor, 
team or family assume this is appropriate.  
 
Royal Children´s Hospital 
At RCH re-education is not routinely coordinated. If families and children and their doctor or 
diabetes educators agree on the necessity of extra education sessions, this is easily organized 
through the diabetes team. 
 
Alice Springs Hospital 
The patients and their families managed at ASH, receive some kind of re-education at every 
check-up. Further organized re-education is arranged through Healthy Living NT (Diabetes 
Australia). 
 
John Hunter Hospital 
At JHH re-education is not arranged on a regular basis, but on a needs basis. The 
endocrinologists and the diabetes team wish re-education could become a regular part of the 
management of children with diabetes. 
6.1.13 Family involvement 
There is a fine balance between giving the child too much responsibility for his or her 
diabetes and being overprotective. How much the parents should be involved in the 
management of their child´s diabetes depends on a lot of factors, including the child´s age and 
personality trait.  
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Oslo University Hospital 
At OUH, young children attend the diabetes appointments with their parents. As they grow 
older many patients choose to come alone. However, because the diabetes team wish to 
involve the parents as long as they are followed up at the children´s clinic, parents must come 
together with their child to at least one appointment every year. If a patient´s glycaemic 
control deteriorates the parents are always encouraged to get more involved and accompany 
their child to all appointments. 
 
Royal Children´s Hospital 
At RCH most often the parents accompany their child to all clinics. The allied health team at 
RCH are very aware of the how difficult it might be for the parents to know how much they 
should participate in their child´s diabetes management, and try their best to give the families 
ongoing guidance and advice. They often remind the families about the importance of trying 
to reduce the burden of the chronic illness for the child by giving as much support and help as 
the child needs at all times. For example, when their child goes through a major psychosocial 
event, e.g., a severe hypoglycemia or a DKA, it is useful to identify a responsible adult to 
prepare and inject insulin and do all blood glucose testing for a while until the child feels 
secure and ready to take over his or her treatment again.  
 
Alice Springs Hospital  
At ASH the parents accompany the children to check-ups.  
 
John Hunter Hospital  
At JHH the children also come with their parents to check-ups.  
6.1.14 Focus on Quality of Life (QoL) in children with type 1 diabetes 
There was limited information available on QoL and mental health problems among children 
with T1D followed up at the four visited hospitals. However, at OUH, RCH and JHH research 
is being conducted. One of ongoing studies at RCH focuses on the use of coping skills in 
diabetes education. At ASH no research on psychological issues has ever been conducted.  
 
Oslo University Hospital  
At OUH they have applied a counselling approach called motivational interview, a patient-
centred method of engaging intrinsic motivation to change behaviour, in order to strengthen 
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the patient´s coping ability [105].  
 
Social activities are not arranged by OUH. Nonetheless, Young Diabetes, which is a part of 
the Norwegian Diabetes Organization, offers courses, summer camps and other social 
activities on a national and a local level.  
 
Royal Children´s Hospital  
No social activities are arranged by RCH. However, all children with T1D and their families 
are encouraged to engage in Diabetes Australia Victoria, the Victorian branch of Diabetes 
Australia, and participate in meetings, extra education sessions, camps and other social 
activities that are arranged by this organization. Each year the organization arranges five 
camps for more than 200 children between four and 17 years with T1D. The goal at these 
camps is to teach young people to manage their diabetes in a fun, safe and supportive 
environment [106]. Doctors, the diabetes team, patients and parents have expressed how 
valuable and popular these camps are. Unfortunately, the waiting lists to attend diabetes 
camps are often long. 
 
Alice Springs Hospital 
ASH does not arrange camps, but the Healthy Living NT arranges camps and other social 
activities for patients with diabetes in NT.  The organisation of these activities is much the 
same as for Diabetes Victoria.  
 
John Hunter Hospital 
Children and adolescents managed at JHH can attend Diabetes camps. They are arranged 
twice yearly by Diabetes Australia in NSW. One camp for children between nine and 12 
years, and one for children between 13 and 18 years. Diabetes Australia in NSW also arrange 
other social activities like Diabetes Victoria and Healthy Living NT do.  
6.1.15 Screening programs 
All the hospitals have screening programs for autoimmune diseases associated with T1D 
(Table 11). The programs include screening for hypothyroidism, hyperthyroidism and celiac 
disease, and is performed at diagnosis and then annually or in the presence of clinical 
symptoms (RCH). In addition, at JHH they check for B12 deficiency.   
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Table 11: Screening for other autoimmune disorders in one hospital in Oslo, Norway 
and three hospitals in three different states in Australia 
 
At OUH, RCH and JHH there are screening programs for some of the late complications 
associated with T1D. Unfortunately ASH does not have this. They check for complications 
when needed (Table 12). Furthermore, no screening is done for detection of psychosocial 
problems, at any of the hospitals. 
 
Table 12: Screening for diabetes complications in one hospital in Oslo, Norway and 
three hospitals in three different states in Australia 
 
Oslo 
University 
Hospital, Oslo  
Royal 
Children´s 
Hospital, 
Melbourne, 
Victoria 
Alice Springs 
Hospital, Alice 
Springs, 
Northern 
Territory 
 
John Hunter 
Hospital, 
Newcastle, New 
South Wales 
Screening for 
autoimmune diseases 
At diagnosis, 
then annually  
At diagnosis 
and if clinical 
symptoms of 
the diseases 
are detected 
At diagnosis, 
then annually 
At diagnosis, 
then annually 
Diseases 
screened 
for 
Celiac disease x x x x  
Hypo- and 
hyperthyroidism 
x x x x 
B12 deficiency    x 
	   Oslo	  University	  
Hospital,	  Oslo	  	  
Royal	  Children´s	  
Hospital,	  Melbourne,	  
Victoria	  
Alice	  Springs	  
Hospital,	  Alice	  
Springs,	  
Northern	  
Territory	  
John	  Hunter	  Hospital,	  
Newcastle,	  New	  
South	  Wales	  
Screening	  for	  
microalbuminuria	  
and	  nephropathy	  
Annually from 11 
years of age after 2 
years from diagnosis 
and annually from 9 
years of age if 5 years 
from diagnosis 
(ISPAD guidelines) 
Annually in adolescents 
after two years of 
diabetes and after five 
years of diabetes if 
prepubertal at diagnosis 
(APEG guidelines) 
Checked when 
needed 
Annually in 
adolescents after two 
years of diabetes and 
after five years of 
diabetes if prepubertal 
at diagnosis (APEG 
guidelines)  
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6.2 Discussion  
6.2.1 Type 1 diabetes - a complex and challenging disease 
T1D is a complicated, serious and widespread chronic disease, associated with a lot of 
challenges physically, psychologically and socially, especially among children and 
adolescents. It is a disease that the patient has to live with - day and night - for the rest of his 
or her life.  Keeping in mind how demanding T1D is for a young person, and also for the 
family, it becomes clear how crucial a highly qualified diabetes care team is. The patient and 
family need ongoing support concerning medical, social and psychological issues. Diabetes 
teams consisting of not only medical personnel, but also social workers, dieticians and mental 
health workers will together offer a more comprehensive diabetes care.  
	   Oslo University 
Hospital, Oslo  
Royal Children´s 
Hospital, Melbourne, 
Victoria 
Alice Springs 
Hospital, 
Alice Springs, 
Northern 
Territory 
John Hunter 
Hospital, Newcastle, 
New South Wales 
Screening	  for	  late	  
retinopathy	  
Annually from 11 
years of age after 2 
years from diagnosis 
and annually from 9 
years of age if 5 years 
from diagnosis 
(ISPAD guidelines) 
Annually in adolescents 
after two years of 
diabetes and after five 
years of diabetes if 
prepubertal at diagnosis 
(APEG guidelines) 
Checked when 
needed 
Annually in 
adolescents after two 
years of diabetes and 
after five years of 
diabetes if prepubertal 
at diagnosis (APEG 
guidelines) 
 
Screening	  for	  	  
neuropathy	  	  
None Yes, in risk patients.  
APEG guidelines:  In 
the presence of poor 
diabetes control, 
clinical evaluation of 
peripheral nerve 
function should occur 
annually  
Checked when 
needed 
Yes, in risk patients.  
APEG guidelines:  In 
the presence of poor 
diabetes control, 
clinical evaluation of 
peripheral nerve 
function should occur 
annually  
Screening	  for	  
hypertension	  
At diagnosis and 
annually 
At diagnosis and, if 
normal, annually 
(APEG guidelines) 
Checked when 
needed 
At diagnosis and, if 
normal, annually 
(APEG guidelines) 
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6.2.2 Organisation of the diabetes management 
Both Australia and Norway have advanced diabetes care programmes, and most patients with 
T1D living here have access to optimal insulin treatment, multidisciplinary diabetes teams 
and strong diabetes organisations. Although the incidence and prevalence of T1D in children 
differed a great deal at the hospitals I visited in the three states in Australia and in the capitol 
of Norway (Table 5), the main principles behind the care and the guidelines that were adhered 
to, were quite similar. Nevertheless I observed a few important differences, especially when it 
comes to treatment regimens and how the follow-up activities were organized. This is 
described in the following 4 sub-chapters. 
6.2.2.1 Treatment regimens 
At OUH approximately 300 children and adolescents are followed up yearly, of which 62% 
are on the insulin pump. At RCH on the other hand care for approximately 1500 children with 
T1D and half of them are on a twice-daily insulin injection regime. At ASH approximately 
eight children with the same diagnosis are followed up, and all these patients are on the twice-
daily insulin injection regime. At JHH, with a number of 360 young patients with T1D, 
multiple injection therapy is the most common regime (54%) (Table 7). However, less than 
half of the children and adolescents at all the four hospitals meet the ISPAD treatment goals 
(HbA1c < 7,5%), implicating that other factors than the insulin treatment regimens might be 
more important to focus on when trying to optimize the diabetes management.  
6.2.2.2 Diabetes teams 
Three of the hospitals (OUH, RCH and JHH) had multidisciplinary teams, but only one of 
these teams includes a psychologist (OUH). The teams are available at all times for the 
patients and their families (phone, email). At ASH the diabetes team lack both a social worker 
and a psychologist. However, an aboriginal liaison is engaged in the management of 
aboriginal children and families. All children diagnosed with T1D at ASH (and their families) 
receive one of the consultants private phone number at the time of diagnosis, thus help and 
support is always available.  
6.2.2.3 Follow-up appointments 
The frequency of the follow-up appointments was somewhat different at the visited hospitals. 
The three hospitals that had multidiciplinary teams as advocated in the ISPAD guidelines, 
also followed ISPAD´s recommendation concerning the frequency of the appointments (every 
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third month). However, at ASH some patients are seen more seldom (twice yearly), even 
though the paediatricians might wish to see them more often. One must keep in mind that 
many of the patients followed up at ASH have long distances to the hospital (up to several 
days of travel). Furthermore, social and cultural issues migh make it more challenging for 
some aboriginal patients to attend their appointments than for non-aboriginals. Fortunately, a 
diabetes educator from the state division of Diabetes Australia (Healthy Living NT) have 
close contact with the families and assist in the follow-up outside the hospital.  
 
At RCH the check-ups are organised differently than at the other three hospitals. At OUH, 
ASH and JHH the patients with diabetes come to their out-patients appointments together 
with other children who have different diagnoses. At RCH all the children with T1D come to 
their check-ups on one of two designated afternoons every week (Diabetes clinics). In my 
opinion this system had several advantages. First of all, the whole team, including educators, 
social workers and dieticians, was available for the families when they waited for the 
appointment with their paediatrician. This made it easy for the families to ask for advice and 
book extra education sessions. One educator and one dietician also had appoinments with 
families on these days. In addition, I recognized how valuable it was both for the children and 
their parents to meet others in the same situation.  Keeping in mind that the number of 
children with T1D is a lot higher at RCH than most other hospitals, the organisation of 
designated diabetes clinic days might be difficult to accomplish at hospitals with fewer  T1D 
patients, and perhaps more importantly at hospitals with less resources. 
6.2.2.4 Insufficient re-education 
In my opinion none of the hospitals I visited had sufficient organised re-education. At OUH 
all children are re-educated once – at the age of 12. At RCH, ASH and JHH re-education is 
arranged solely on a needs basis. Perhaps, the diabetes teams should consider organising re-
education on a more regular basis. I have seen how easily children and families forget what 
T1D really is, and how their diabetes control may deteriorate when it becomes unclear what 
causes hypo- or hyperglycaemias and why insulin is crucial.  Implementation of organised re-
education might help the patients and families to get a better understanding of the disease, 
thus cope better with it. It is important to remember that diabetes is a chronic and progressive 
disease and that the young patient´s needs continuously change as they meet the challenges 
associated with growth and development. Therefore, all forms of education and support must 
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be customized and relevant for the different ages and stages of the patient group, again 
emphasizing the value of re-education on a regular basis.  
6.2.3 Coping with the diabetes 
The diabetes care team have an important task in helping the children and their families to 
accept the diagnosis. Accepting one´s condition is essential.  When participating in diabetes 
clinics, especially in the education sessions with newly diagnosed children, I recognised the 
importance of understanding what T1D is, accepting it and learning how to cope with it. 
When the patient copes well with his T1D he will feel that he is in control of the condition 
and that again might increase his QoL and glycaemic control. The patients should be taught 
coping skills from the time of diagnosis and these skills should be reassessed regularly, for 
example in re-education sessions. The training should be customized, taking into account the 
patients age, personality trait, social situation, resources etc. 
6.2.4 The family´s role 
Not only the patient must learn how to cope, so must the family. When a child is diagnosed 
with diabetes, the whole family receives a chronic diagnosis. How families cope varies 
greatly.  Getting a child with a chronic disease is without doubt frightening and demanding. 
Some parents even develop anxiety and other mental health issues. Most of the responsibility 
for the care of children with diabetes rests with the family, thus when parents cope 
inadequately, this will consequently have negative impact on the child. Even in older children 
and adolescents who have taken over most of the responsibility for their treatment, the way 
the whole family cope is still essential. As the children grow older the parent´s role remains 
important, but must change from that of a parent to more of a coach [107]. This requires 
parents with a good understanding of the disease and with their own coping skills in place. 
Therefore early assessment of family dynamics is important, and help and support from the 
diabetes team have to be tailored to each individual family.  
6.2.5 The relationship between quality of life and metabolic control 
Achieving good quality of life and strict metabolic control is an enormous challenge for the 
patient, his or her family and the health care team. Childhood and adolescence is a time filled 
with critical changes associated with growth and development, both physically and 
psychologically, which makes it extraordinary challenging to handle a chronic diagnosis. 
Youth are vulnerable. Finding an identity is an important task in childhood and adolescence, 
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and every child and teenager wants to be normal, to be accepted and succeed at school, in 
sports and among friends. Diabetes interferes with these needs. It affects the young persons 
daily life and makes them feel different. Adolescents with T1D are the group of patients with 
the worst glycaemic control compared to other age groups [108, 109]. The growth and the 
hormonal changes in this period of life make optimal insulin treatment even more 
complicated. A reduced glycaemic control might lead to reduced quality of life and vice 
versa. Studies have shown that psychological treatment can slightly improve glycaemic 
control in young people with diabetes [83, 110]. This should draw attention to an increased 
focus on how to optimize the patients QoL. More research on coping skills, motivational 
enhancement therapy and cognitive behavioural therapy as tools in the diabetes treatment is 
required.  
6.2.6 Strengthening in psychosocial support 
Many children and adolescents with T1D report poor wellbeing. Furthermore, they are more 
prone to psychological disorders such as depressions and eating disorders than their peers. If 
children develop mental health problems in addition to their diabetes, this will necessarily 
reduce their quality of life, affect their glycaemic control and increase their risk of early 
diabetes complications.  
 
Keeping in mind the fact that psychological problems might be one of the most important 
complications associated with diabetes in young patients, a strengthening in psychosocial 
support to the patients and their families should be proposed. The diabetes teams I met in 
Australia lack a psychologist, which is an acknowledged weakness. At JHH and at RCH they 
are working hard to get enough funding to employ a psychologist or psychiatrist. Even though 
OUH in Oslo has a psychologist on the team, this is just a part-time employment and the need 
of more psychological expertise is required.  
6.2.6.1 Screening for psychological problems 
At all the hospitals I visited screening for late complications is performed.  OUH follow the 
ISPAD guidelines for screening of complications. RCH and JHH follow the APEG 
guidelines, which are quite similar (Table 12). However at ASH screening for complications 
is only done when the health professionals consider this necessary (Table 12). Moreover, all 
the four hospitals lack screening programs for psychological problems.  
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Increased focus on mental health and QoL should start at the time of diagnosis with mental 
health screening as part of the established diabetes complication screening program. Early 
detection and treatment of emotional problems might increase the patients QoL and thus 
perhaps their glycaemic control.  It may also reduce the risk of developing more severe 
psychological problems.  
6.3 Conclusion 
Achieving both metabolic and psychological stability in children and adolescents with T1D 
requires a multidisciplinary diabetes team that is equipped to provide physical, social and 
psychological support. A psychologist should be a compulsory part of the diabetes team. 
Early psychological interventions, assessment of family dynamics, introduction to regular re-
education and practice in coping skills, together with encouragement and optimism, are 
important factors in the complex organisation of diabetes care for young people. 
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QUESTIONNAIRE – TYPE 1 DIABETES IN CHILDREN  
 
THE QUESTIONNAIRE IS DESIGNED TO GATHER INFORMATION ABOUT CHILDREN 
WITH DIABETES ≤ 15 YEARS OF AGE. THE INTERVIEW WILL BE SPLIT IN TWO AND 
EACH ROUND SHOULD LAST A MAXIMUM OF 1 HOUR. 
 
The first part of the interview is designed to map T1D in children at a national or regional 
level. Each country has a number code (see list). The regions/counties/states are indicated by 
names.  The interviewer fills out this first part of the interview based on information available 
on the Internet and other places. She will then talk it thorough with the local informant. 
 
The second part of the interview is designed to map T1D in children at the local 
hospital/treatment facility. The interview contains multiple qualitative questions; therefore the 
interview will be tape-recorded. The tape recordings will be transcribed before the analysis 
takes place. 
 
The schemes do not contain personal sensitive information. 
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PART 1 
 
Country (code):  
Region/county/state:  
Date:  
Informant: name/occupation:  
Interview by:  
 
Incidence  
 
 
1. What is the annual incidence of the different types of diabetes in this country (enter the 
number and percentage)? 
o Type 1 diabetes  
o Type 2 diabetes  
o Gestational diabetes  
 
2. What is the incidence of type 1 diabetes (T1D) among children under 15 years of age? 
 
3. How is the distribution in the following groups of ages (estimated):   
o <5 years    
o 5-<10 years   
o 10-<15 years   
o > 15 years 
 
 
4. Among children with T1D, what is the gender distribution?  
 
5. What are the overall proportions of the following ethnicities in this country: 
o White / European background (non-Hispanic whites)  
o Black / African background  
o Middle-East / North-African  
o Indian subcontinent  
o East-Asia 
o Middle- and South American (Hispanics)  
o Indigenous (specify) 
o Mixed (or unclassified) 
 
6. How many children with diabetes are 
o White / European background (non-Hispanic whites)  
o Black / African background  
o Middle-East / North-African  
o Indian subcontinent  
o East-Asia 
o Middle- and South American (Hispanics)  
o Indigenous (specify) 
o Mixed (or unclassified) 
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8.1 Prevalence  
7. What is the total prevalence of T1D among children?  
 
8. What is the prevalence of T1D among children in the following age groups?  
o <5 years:  
o 5-<10 years:  
o 10-<15 years:  
o ≥ 15 (adults):  
 
Mortality 
9. What is the average life expectancy in the country for women?  
 
10. What is the average life expectancy in the country for men 
 
11. What is the average life expectancy among female patients diagnosed with                   
T1D  before the age of 15?  
 
12. What is the average life expectancy among male patients diagnosed with T1D before the 
age of 15?  
 
National health  
13. How many doctors per citizen?  
 
14. Is there a geographical difference in availability of doctors? 
 
15.  What is the gross domestic product (GDP) of the county?  
 
16. What is the total expenditure on health as a percentage of the GDP?  
 
17.  What is the general government expenditure on health as percentage of total expenditure 
on health?  
 
18. What is the private sector expenditure on health as percentage of total expenditure on 
health?  
 
19. What is the general government expenditure on health as percentage of general 
government expenditure?  
 
20. Are there any support systems that finance the costs associated with diabetes medication 
and equipment? 
 
21. If the answer is yes on question 20, which proportion of the following medication is 
financed 
o Insulin 
o Antidiabetic drugs 
o Glucagon 
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22. If yes on question 20, which of the following materials is financed? 
o Syringes: 
o Needles: 
o Insulin pen: 
o Insulin pump: 
o Materials for the insulin pump: (needle, catheter, reservoir..): 
o Home Blood Glucose meters: 
o Blood glucose test strips:  
o Finger-pricking devices: 
o Lancets for finger-pricking: 
o Continuous subcutaneous glucose monitoring devices: 
o Urine sticks to check for ketonuri: 
o Other:_____ 
 
23. If the answer is yes on question 20, does the patient have to pay anything? If so, how 
much? (%) 
 
24. Who brings the child to their check-ups? 
o Mum 
o Dad 
o Other:_______ (specify) 
 
25.  Are there any laws/public rights for parents to get time off work to take their children to 
check ups? 
 
26. Do parents with ill children get “sick-days”? 
 
27. Do parents with chronic ill children get extra ”sick-days”?  
o No = 0 days 
o 1-3 days 
o 4-6 days 
o 7-9 days 
o 10-12 days 
o 13-15 days 
 
28. Are there national guidelines for the management of children with T1D? 
 
Patient organizations 
29. Are there any national organizations for patients with T1D? 
o For children 
o For children and adults 
o For adults only 
o No 
 
30. Are there any local organizations for patients with T1D? 
o For children 
o For children and adults 
o For adults only 
o No 
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31. What do the patient organizations offer the children and their parents? 
o Websites  
o Telephone  
o Courses  
o Information meetings  
o Holiday offers 
o Other:_________ 
 
Register for diabetes 
32. Is there a national diabetes register? 
o For children  
o For adults 
o For adults and children 
o No 
  
33. If yes on question 32, what data is registered? 
o Incidence  
o Acute complications  
o Late complications  
o Other: 
 
 
Complications 
 
34. What is the incidence of acute diabetes complications among children under 15 years of 
age? 
o Diabetic ketoacidosis (with hospitalization)  
o Grave hypoglycemia (unconscious with or without convulsions)  
 
35. What is the incidence of late diabetes complications among children under 15 years of 
age? (estimated percentage) 
o Retinopathy 
o Nephropathy 
o Neuropathy 
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Country (code):  
Region/county/state:  
Date:  
Informant: name/occupation:  
Interview by:  
 
 
 
PART 2 
Hospitalizations and number of hospital beds 
 
36. How many children <15 years with T1D are admitted to hospital annually in the following 
wards (The total number of hospitalizations including rehospitalization) 
o Children ward  
o Adolescents ward 
o Internal medical ward 
 
 
37. How long are the children managed in the pediatric department? (up to what age)  
 
38. Is there an adolescent department?  
 
39. If yes on question 38, which group of age attend to the adolescent department? 
 
40. What is the maximum number of beds in the ward?   
 
41. How often has the ward been full during the last 6 months? (regardless of the reason for 
the hospitalisation)  
 
42. How many children with T1D are followed up at the local hospital today?  
 
43. How is the gender distribution among the children that are followed up at the local 
hospital?  
 
 
Diagnostics 
44. Who usually make the diagnosis? 
o General practice 
o Specialised health service  
o Nurse 
o Other:_________ 
 
45.  What is the average age at diagnosis?  
 
46. What are the classical symptoms that make the patient and his or her parents contact a 
doctor?  
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47.  Which diagnostic criteria have to be fulfilled to make the diagnose T1D? 
o International guidelines 
o ADA 
o Other 
 
48. Where are recently diagnosed juvenile diabetics treated the first time? 
o Out-patients clinic  
o Hospital ward with beds  
 
49. If the patient is admitted to hospital, what is the average length of stay?  
 
50. Which diagnostic criteria do you use for DKA? 
o Hyperglycemia 
o Standard Bicarbonate (< 15 mmol)  
o pH (< 7,3) 
o Urine ketons 
 
51. What proportion of children has DKA at diagnosis? Treatment and follow up 
 
52. Who participates in the treatment and follow up of children with T1D? 
o Nurse  
o Doctor  
o School nurse 
o Social worker  
o Nutritionist  
o Psychologist  
o Other 
o Multidisciplinary team  
 
 
53. Does the child with T1D have one particular contact person? If yes, specify: 
 
54. When the diagnosis is made who is responsible for the follow-up? 
o Specialist (endocrinology)  
o Hospital doctor 
o Nurse 
o General practitioner  
o Other:_________ 
 
 
55.  Who are educated (at the time of the diagnosis, and after discharge)? 
o The child  
o Parents  
o School  
o School nurse  
o Nursery  
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o Activity leaders/coaches  
o Others:  
o No one 
 
 
56. Does the hospital have access to interpreters when they have patients that do not 
speak/understand English?   
 
57. How is the education organized? 
o Training in groups 
o Individual training  
o A combination of both 
 
58. Do you organize re-education?  
 
59. At what age is the re-education organized?  
 
60. How is the reeducation organized? 
o Training in groups 
o Individual training 
o A combination of both 
 
61. How do parents participate in the treatment and follow up? 
 
62. Is carbohydrate counting used systematically when calculating the insulin bolus in 
relation to food? Yes 
 
 
63. Do the adolescents get contraceptive counseling 
 
64. Have you experienced unintended pregnancies in this group of patients 
 
65. What are the characteristics of these patients? (ethnicity, socioeconomic status etc)  
 
66. What types of treatment/treatment regimens are available for children with T1D at the 
local hospital? 
o Syringes 
o Needles 
o Insulin pen 
o Insulin  
o Continuous Subcutaneous Glucose Monitoring  
o Others 
 
67. How many patients use multi injection (insulin > 3 times a day) therapy? 
 
68. What proportion of the patients (in percentage) follow the different treatment regimens 
listed 
o Insulin  
o Multiinjection therapy without pump  
o Injections less than 4 times a day 
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o Others 
 
69. Among the children under multi injection therapy what type of insulin preparations are 
used? (%) 
o Premixed insulin preparations  
o Intermediate-acting insulin + rapid-acting insulin 
o Analogues (Comment: Which combinations: ____________) 
 
 
70. With sight to multi injection therapy are there any different strategies for insulin therapy 
concerning the child’s age? 
 
71. Who does the patient and his or her parents contact if the child is acute ill? 
o Specialist  
o Contact person 
o General practitioner (GP) 
o Emergency room   
o Other 
 
 
Treatment goals 
 
72. Are the ISPAD treatment goals adhered to?  
 
73. If no, are other guidelines followed?  
 
74.  What are the treatment goals 
o HbA1c < 7,5 %   
o Other 
 
75. What proportions (%) of patients achieve the treatment goals? 
 
76. How often do the children attend diabetes health check ups? 
 
77. What proportions of the patients attend their appointment?  
 
78. What are the characteristics of the patients who not attend to their appointment? 
 
79. Is there a screening program for autoimmune diseases?  
 
80. If yes on question 79, which diseases are included in the screening 
o Celiac disease  
o Hypothyroidism / hyperthyroidism  
o Others  
 
81. If yes on question 79, how often is the screening performed 
o At each check up 
o Annually  
o Other 
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82. Are there any screening program concerning late diabetes complications among children 
with diabetes?  
 
83. If yes on question 82, what kind of late diabetes complications are included in the 
screening program among children with diabetes? Specify which methods are used in the 
screening. 
o Retinopathy  
o Nephropathy  
o Neuropathy  
o Others 
 
84. If yes on question 82, how often is the screening performed 
o At every check up: 
o Annually: 
o Other 
 
 
Quality of life and mental health: 
 
85. What assistance do the children with T1D and their parents receive in relation to school, 
hobbies and sports?  
 
86. Are there social activities arranged for the children and their parents?  
 
87. What kind of social activities are arranged? And who organises them?  
 
88. Have you conducted/do you conduct research on the quality of life in the children with 
diabetes?  
 
89. Are drug or alcohol abuses a problem among children with T1D? 
 
90. If yes on question 90, what kind of abuse? (Alcohol, drugs, medications) 
 
91. If yes on question 90 what are the characteristics of these patients? (gender, ethnicity, 
socioeconomic status etc) 
 
92. What is the proportion (percentage) of acute diabetes complications among children with 
T1D under the age of 15? 
o Diabetic ketoacidosis 
o Hypoglycemic shock with unconsciousness and/or convulsions 
o Other 
 
93. What is the proportion (%) of long-term complications among children under the age of 15 
years? And how old are they? 
o Retinopathy: 
How many have been treated with laser? 
o Nephropathy: 
o Neuropathy: 
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o Hypertension  
How many get anti hypertension treatment? 
 
94. What is the proportion (%) of long-term complication among adults who got the diagnose 
T1D before they turned 15 years? 
 
      (The following must be discussed: How old were the patients when they where diagnosed 
with T1D? How many years diabetes duration at onset of the late complication?) 
 
95. Is overweight a problem among children with T1D? 
  If yes: 
o Are there any differences between gender, ethnicity, socioeconomic background etc? 
o In which group is the prevalence of overweight highest? 
o What kind of prevention and treatment regimens does the hospital have? 
o Are the treatment regimens effective? 
o Do children with overweight in practice have significant more complications than 
children with normal weight? 
o Are there other problems related to overweight and T1D? 
 
 
